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Ribosomopathies are a class of diseases resulting from mutations in genes 
encoding ribosomal proteins and ribosome biogenesis factors. Pleiotropic 
clinical presentations of different ribosomopathies has been taken as evidence 
of specialized ribosomes. Alternatively, gene dosage effects have been 
proposed to account for the observed differences. A yeast genetics approach 
was used to address this issue. Due to a historical gene duplication event, S. 
cerevisiae cells harbor two ohnologs for most ribosomal proteins. Deletion of 
one yeast ribosomal protein ohnolog was used to mimic haploinsufficiency in 
diploid cells (i.e. pseudo-haploinsufficient yeast). Further, insertion of a second 
copy of the undeleted ohnolog into the locus of the deleted ohnolog enabled 
separation of effects due to gene dosage from those due to ribosomal protein 
ohnolog identity. We found that significant changes in translational fidelity in 
the ribosomal protein ohnolog deletion strains were corrected by ohnolog 
  
duplication. Changes in gene dosage, particularly as they may affect the 
abundance of an enzyme as central as the ribosome, can impart stress through 
far reaching effects on cellular metabolism. Thus, as an orthogonal approach, 
we also examined the stress profiles of cells harboring the cbf5-D95A allele 
(model of X-linked Dyskeratosis Congenita) and the rps23a-R69K allele (model 
of MacInnes Syndrome). RNA-seq analysis revealed increased expression of 
proteins involved in response to oxidative stress in cbf5-D95A cells. Growth 
curve analysis revealed a longer plateau of the cbf5-D95A cells upon reaching 
stationary phase, suggestive of a pre-adaptive stress response. Decreased 
ROS abundance, tunicamycin resistance and increased basal levels of HAC1 
mRNA in the mutant cells support this hypothesis. Similar results were 
observed with regard to the ohnolog deletion strains. Taken as a whole, these 
data support the gene dosage model as opposed to the specialized ribosome 
hypothesis with the caveat that this conclusion is limited to yeast cells growing 
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Chapter 1: Introduction 
The ribosome 
The ribosome is the molecular machine responsible for the synthesis of 
proteins. This macromolecule is older than cellular life itself, dating back ~4 
billion years1,2. It is hypothesized that cellular life has evolved around the 
ribosome. Ribosomal RNAs (rRNAs) and ribosomal proteins are assembled 
into ribosomes in a complex maturation process (Figure 1). The large 
ribosomal subunit (60S) in the yeast ribosome is composed of 5S, 5.8S, and 
25S rRNAs, and 33 ribosomal proteins3. The small ribosomal subunit (40S) is 









Figure 1. Maturation of ribosomes into large (60S) and small (40S) 
subunits 
Sequential assembly of the pre-ribosome intermediates happens with the 
assistance of ~200 assembly factors (shown in purple). rRNAs are represented 
in red (early), orange (middle), or yellow (late), and their sedimentation 
coefficient is displayed. Ribosomal proteins are shown in teal and assemble 
into the pre-ribosomes at all stages of maturation. Figure from Woolford and 
Baserga, 20133. 
 
The two ribosomal subunits function together to decode messenger 
RNA (mRNA) into proteins4–6. The small subunit contains the decoding center 
where base pairing between the mRNA codon and the transfer RNA (tRNA) 
anticodon allow for discernment of correct aminoacyl tRNAs (Figure 2). The 
large subunit contains the peptidyl transferase center where as the name 
indicates peptidyl transfer occurs via a transesterification reaction wherein the 
nascent peptide is transferred from a peptidyl tRNA in the ribosomal P-site onto 







Figure 2. Peptidyl transferase center and decoding center of the ribosome 
Ribosome with A-, P-, and E- sites labeled. Large subunit is shown in purple, 
and small subunit in grey. Aminoacyl tRNA is shown in orange at the A-site, 
and the peptidyl tRNA is shown in red on the P-site. The location of the peptidyl 
transferase center and decoding center are highlighted. Image adapted from 
Blanchard et al., 20045. 
 
Ribosomopathies 
Given the centrality of the ribosome for life, the discovery that organisms 
could survive despite the presence of mutations in genes encoding ribosomal 
proteins was somewhat surprising. In Drosophila melanogaster, the 
appearance of the Minute phenotype (characterized by slow development, 
small size, and thin bristles) has been independently attributed to mutations in 





reduced overall protein synthesis were the first indication that the ribosomal 
deficiencies may underlie certain human disease states7,8,17,9–16.  
This class of disorders, called ribosomopathies, is often characterized 
by anemia and in some cases bone marrow failure early in life, and by cancer 
if patients survive in early adulthood 18–20. This transition from a 
hypoproliferative phenotype (anemia) to a hyperproliferative phenotype 
(cancers, such as leukemia) is known as Dameshek’s riddle18,21. In a classic 
paper published in 1967, Dr. William Dameshek proposed that some sort of 
repair mechanism was able to react to an initial damage, thus providing at least 
some cells the ability to grow, albeit abnormally21. The subsequent 
identification of mutations affecting the ribosome  as underlying this class of 
diseases, termed ‘ribosomopathies’, marked a critical breakthrough toward 
understanding this paradox18. 
In ribosomopathies, the first insult to a cell is the mutation in a ribosomal 
protein or ribosome biogenesis factor. This leads to ribosome biogenesis 
defects and changes in protein expression. The population of cells carrying 
these mutations are under selective pressure to synthesize enough ribosomes. 
Revertants or cells carrying second site suppressor mutations that inactivate 
ribosome biogenesis quality control mechanism thus have a selective 
advantage. Although these cells are able to synthesize enough ribosomes, they 
remain defective in their ability to carry out accurate protein synthesis (Figure 
3)18,22. A well-studied example involves cells carrying the R98S mutation in 





and a slow growing phenotype. Hematopoietic stem cells require high rates of 
cellular proliferation in order to supply enough erythrocytes to supply the body 
with a constant supply of new blood cells.  Those carrying the RPL10-R98S 
mutation are under selective pressure to proliferate, selecting for suppressor 
mutations that eventually cause the cancerous phenotype, T-cell acute 




Figure 3. Ribosomopathies: Transition from a hypoproliferative to a 
hyperproliferative phenotype 
Model of ribosomal protein defect leading to a hypoproliferative phenotype. 
This places selective pressure on the cells to acquire secondary mutations. 
These mutations could then cause a hyperproliferative phenotype, leading to 
clonal expansion of cells with an altered translational phenotype. Figure from 
Sulima et al., 201722. 
 
An extensive list of ribosomopathies have been characterized. This work 





Table 1. A selective list of ribosomopathies, including their clinical 





































Absence of the 
spleen 
RPS0 uS2 










Table adapted from Narla and Ebert, 2010 and Nakhoul et al., 201419,20. 
 
Diamond Blackfan Anemia 
Diamond-Blackfan Anemia (DBA, OMIM #105650) was first identified in 
1938 as a hypoplastic anemia24. DBA is an autosomal dominant disease that 
occurs at a rate of between 5 and 7 people per million live births25–30. Most 
patients present with macrocytic anemia (defined as red blood cells larger than 
normal, and with lower levels of hemoglobin)26–28,30–33, bone marrow 
failure27,29,33, short stature25,28,30, craniofacial abnormalities25,28–30,32,34, heart 
congenital malformations28,30,32,34, and thumb abnormalities25,32,34.  
To date, DBA has been associated with mutations in 19 ribosomal 





RPS17, RPS24, RPS26, RPS27, RPS28, RPS29, RPL3, RPL5, RPL9, RPL11, 
RPL15, RPL18, RPL26, RPL27, RPL31, and RPL35A27,28,40,41,30,31,34–39. DBA 
tends to be caused by inactivating mutations, resulting in haploinsufficiency for 
the ribosomal proteins they encode (eS19, eS7, eS10, eS17, eS24, eS26, 
eS27, eS28, uS14, uL3, uL18, uL6, uL5, eL15, eL18, uL24, eL27, eL31, and 
eL33, respectively).  Patients with mutations in GATA1, which encodes a 
transcription factor involved in erythroid differentiation, and TSR2, which 
encodes a protein involved in pre-rRNA processing and which binds directly to 
eS26, have also been identified36,42,43. DBA patients have a higher risk of 
cancer, most commonly in the form of acute myeloid leukemia and osteogenic 
sarcoma30,32,39,44.  
 
Isolated Congenital Asplenia 
Isolated Congenital Asplenia patients (ICA, OMIM #271400) are born 
without a spleen and have no other developmental defects29,45–47. This 
autosomal dominant ribosomopathy afflicts 0.51 people per million live 
births29,46,48. Patients with ICA are more susceptible to bacterial infections, and 
a large portion die of sepsis in childhood29,48. De novo heterozygous mutations 
in gene RPSA, encoding ribosomal protein uS2, leading to haploinsufficiency 







5q- Syndrome (OMIM #153550) is due to deletion of a portion of the long 
arm of chromosome 5. This results in haploinsufficiency for the RPS14 gene, 
encoding ribosomal protein uS11, a component of the 40S ribosomal subunit49–
53. This disorder affects 1 in 20,000 people in the USA54. This syndrome is a 
subtype of myelodysplastic syndrome, which in a quarter of the patients 
progresses to acute myeloid leukemia19,29,51,53,55. Patients present with 
macrocytic anemia, and high platelet counts52,53,55–57.  
 
X-linked Dyskeratosis Congenita 
X-linked Dyskeratosis Congenita (X-DC, OMIM #30500) is a 
ribosomopathy caused by mutations in the DKC1 gene. DKC1 encodes 
dyskerin, a conserved pseudouridine synthase that catalyzes the conversion of 
certain uridines in rRNA to pseudouridines58–60. Small nucleolar RNAs 
(snoRNAs) called H/ACA RNAs guide pseudouridylation61–63 by transiently 
base pairing with the rRNA and specifically targeting the uridines to be 
modified64. The H/ACA RNAs contain two hairpin structures, the H domain and 
the ACA box, separated by a single stranded region. Dyskerin is conserved 
from humans through yeast, where the gene is called CBF558,65–67. One in 







MacInnes Syndrome (OMIM #617412) is a ribosomopathy caused by 
mutations in the RPS23 gene, encoding protein uS1268. This novel 
ribosomopathy was identified by our collaborator Dr. Alyson MacInnes. The two 
known patients presented with short stature and craniofacial malformations68, 
similar to what is observed in DBA patients. One of the patients was additionally 
diagnosed with intellectual disability and autism spectrum disorder68. Contrary 
to DBA, MacInnes Syndrome patients did not present with anemia or any other 
hematologic symptoms68. 
 
Ribosome biogenesis defects in ribosomopathies 
Ribosomopathies are due to genetic abnormalities in ribosomal proteins 
or ribosome biogenesis factors. As such, it was deemed important to study the 
effects of the mutations associated with ribosomopathies on ribosome 
biogenesis. The central part of ribosome biogenesis is pre-rRNA processing 
(Figures 4 and 5), around which ribosomal proteins and ribosome biogenesis 
factors assemble as described above. Pre-rRNA processing has been studied 






Figure 4. Yeast pre-rRNA processing 
The 35S pre-rRNA is transcribed by RNA polymerase I, while pre-5S rRNA is 
transcribed by RNA polymerase III. External and internal transcribed spacers 
(ETS and ITS) are removed by a series of endonucleolytic and exonucleolytic 
steps during ribosome assembly. This series of processes starts in the 
nucleolus and continues through the nucleoplasm and cytoplasm, as the 
forming ribosome subunits are exported out of the nucleolus. Figure from 







Figure 5. Human pre-rRNA processing 
Depiction of pre-rRNA processing in human cells. External and internal 
transcribed spacers (ETS and ITS) are removed by a series of endonucleolytic 
and exonucleolytic steps during ribosome assembly. This series of processes 
starts in the nucleolus and continues through the nucleoplasm and cytoplasm, 
as the forming ribosome subunits are exported out of the nucleolus. Figure from 







Ribosomopathies are associated with ribosome biogenesis defects 
Ribosome biogenesis defects associated with ribosomopathies has 
been most well documented in patient-derived DBA cells and in models of this 
disease. The yeast eS19 protein shares 50% identity with the human eS19. It 
is encoded by ribosomal protein genes RPS19A and RPS19B ohnologs, 
closely related genes resulting from a genome duplication event that occurred 
in Saccharomyces cerevisiae approximately 100 million years ago69. Analysis 
of ribosome biogenesis in yeast rps19bΔ cells revealed that 18S rRNA 
production is compromised as documented by an increase in accumulation of 
35S pre-rRNAs70. Polysome profiling in rps19bΔ cells revealed a smaller 40S 
peak and fewer polysomes70. Independently of which yeast rps19 ohnolog was 
deleted, 40S subunits were retained in the nucleus70, presumably because of 
a defect in small subunit assembly that affects nuclear export. 
Ribosome biogenesis defects have been documented in cells derived 
from DBA patients, as well as in cells in which a ribosomal protein associated 
with a DBA diagnosis had been knocked down by either siRNA or shRNA. 
Fibroblasts derived from DBA patients with mutations in RPS19 showed 
accumulation of 21S pre-rRNA71. Hematopoietic progenitor TF-1 cells in which 
RPS19 was knocked down had reduced 18S rRNA levels, accumulation of 21S 
pre-rRNA, and a reduction in 40S subunits on polysome profiles72. Similarly, 
HeLa cells in which RPS19 had been knocked down displayed a smaller 40S 





HeLa cells in which RPS10 or RPS26 mRNAs were knocked down by 
siRNA displayed a reduction in 18S rRNA27. Lymphoblast cell lines (LCLs) 
derived from DBA patients with mutations in either RPS10 or RPS26 showed 
higher levels of 18S-E pre-rRNA, suggesting a defect in processing 18S 
rRNA27. RPS27 knockdown on K562 cells (erythroid lineage) led to increased 
accumulation of 30S pre-rRNA, and a decrease in abundance of 21S and 18S-
E pre-rRNA73, indicating an earlier defect in rRNA processing. Observations 
regarding accumulation of pre-rRNAs and changes to polysome profiles in cells 
that either carry mutations to RPS19, RPS10, RPS26, or RPS27, or cells which 
have had expression of the mRNAs encoding their respective proteins knocked 
down indicated defects in rRNA processing required for small ribosomal subunit 
assembly. 
Studies examining the effects of large subunit ribosomal proteins 
implicated in DBA diagnosis have also revealed ribosome biogenesis defects. 
Lymphoblastoid cells from DBA patients carrying mutations in RPL5 and 
RPL11 showed increase in accumulation of 32S, 30S, 18S-E, and 12S pre-
rRNAs30. Knockdown of RPL5 and RPL11 in HeLa cells led to a decrease in 
the 60S peak in polysome profiles30. Knock down of RPL15 in HeLa cells led 
to a decrease in the 60S peak and half-mers appearing in the polysome profile 
of these cells28. In HeLa cells in which RPL15 has been knocked down, there 
was an increase in accumulation of 32S and 12S pre-rRNAs (precursors to 28S 





pre-rRNA28. The same observations were made in HeLa cells in which RPL26 
had been knocked down37.  
Additional studies of DBA-associated mutations in large subunit 
ribosomal proteins generated similar observations. Sucrose gradient 
fractionation of RPL3, RPL19, and RPL26 siRNA knock downs in HeLa cells 
revealed decreased levels of  free 60S subunits, as well as decreased in 80S 
monosomes and polysomes peaks37. Knock down of RPL19 in HeLa cells led 
to accumulation of 32S pre-rRNA, which was also seen in lymphoblasts from a 
DBA patient carrying a heterozygous RPL19 mutation37. Knock down of RPL26 
in HeLa cells resulted in decreased abundances of 30S, 21S, and 12S pre-
rRNAs, and an increase in 41S pre-rRNA37, suggesting an earlier defect in 
rRNA processing. The effects seen in levels of 41S, and 21S pre-rRNAs were 
recapitulated in patient cells with a mutation in RPL2637. Knock down of RPL27 
in K562 cells (erythroid lineage) led to accumulation of 32S pre-rRNA73.  UT-
7/Epo cells (human leukemic cell lines requiring erythropoietin for growth) 
where RPL35A had been knocked down displayed a smaller 60S subunit peak 
in a polysome profile, consistent with the accumulation of 45S and 41S pre-
rRNA observed in these cells39,74. These observations were consistent with 
defects in processing of rRNAs required for assembly of the large subunit of 
the ribosome. 
In sum, it is clear that ribosome biogenesis is a common denominator in 
DBA, both in patient-derived cells and in DBA models. Depending on the 





small or large subunit were observed. It is also clear that mutations in small 
subunit proteins reduced the size of 40S peaks, and that large subunit protein 
mutants conferred reductions in size of 60S peaks in polysome profiles. Taken 
together, this information supports the hypothesis that DBA pathology is likely 
due to defective ribosome synthesis, and not due to a specialized function of 
any one ribosomal protein39. 
Ribosome biogenesis defects have been documented in other 
ribosomopathies as well. With regard to ICA, uS2 is a component of the small 
ribosomal subunit and when deleted leads to lower amounts of 18S-E pre-
rRNA, indicating that there is a defect in processing 21S pre-rRNA (precursor 
to 18S rRNA, in the small subunit of the ribosome)75. Regarding 5q- syndrome,  
uS11 haploinsufficiency leads to accumulation of 30S pre-rRNA, and lower 
levels of 18S-E pre-rRNA53, suggesting defects in 18S rRNA processing.  
Translational Fidelity 
Although the effects of mutations involved in ribosomopathies on 
ribosome biogenesis have been well documented, there remains a large gap 
in knowledge with respect to the effects of these mutations on translational 
fidelity.  Faithful translation of a message depends on three factors: 1) 
aminoacyl-tRNA synthetases must pair the correct amino acid and tRNA, 2) 
ribosomes must select cognate aminoacyl-tRNAs, and 3) ribosomes must be 
able to proofread and correct wrongful selection events76–81.  
In order to understand the effects of ribosomopathies on translational 





‘normal’ error rates.  The frequency of errors by the aminoacyl-tRNA synthetase 
is 10-6 or lower due to its editing capabilities79,82,83. The ribosome incorporates 
a missense amino acid at a rate of 10-4 to 10-5 in wild-type (WT) cells 79,84–86. 
Nonsense suppression occurs at a rate of 3 to 4 x 10-4 at UAA and UAG codons 
in WT cells87. The rate of non-programmed ribosomal frameshifting is ~ 0.01% 
for WT ribosomes88,89. The frequency of proofreading error by the ribosome is 
0.055% in WT cells90. In general, these parameters ensure that error rates are 
on the order of 10-3 to 10-4  errors per codon in WT cells76,79,91–95. 
 
Translational fidelity defects 
While a high level of translational accuracy is required for proper protein 
synthesis, there are exceptions to the rules. These are called translational 
recoding events. This section will give overview of four examples of recoding. 
 
Programmed -1 Ribosomal Frameshifting (-1 PRF) 
Programmed -1 ribosomal frameshifting (-1 PRF) was first identified in 
the region of overlap between the gag and pol genes of retroviruses96–98 
(Figure 6). In retroviruses and many other RNA viruses, -1 PRF events encode 
C-terminally extended peptides, allowing viral genomes to maximize their 






Figure 6. -1 PRF events in viruses 
-1 PRF events in viruses encode C-terminally extended proteins for translation 
of gag and pol proteins. Controlled rates of -1 PRF allow for correct 
stoichiometric ratios to form a mature infectious virion. Figure from Advani, 
2015100. 
 
Numerous studies of viral -1 PRF signals led to the determination of the 
basic elements of 1- PRF signals. They are divided into three parts, consisting 
of a heptameric slip site with the consensus sequence of N NNW WWH (where 
N denotes any 3 identical nucleotides, W denotes 3 consecutive As or Us, H 
denotes any nucleotide but G, and spaces indicate incoming frame), a short 







Figure 7. Structure and mechanism of -1 PRF signals 
(A) -1 PRF signal consist of a heptameric slippery site, a short spacer, and a 
downstream secondary structure. (B) The downstream structure, in this case a 
pseudoknot, forces the elongating ribosome to pause with its A- and P-site 
tRNAs positioned over the slippery site. (C) The ribosome slips one base in the 
5’ direction, and non-wobble base pairing occurs between the tRNAs and the 
slippery site. (D) Once the downstream structure is resolved, the ribosome 
resumes translation in the -1 frame. Figure from Belew and Dinman, 2015102. 
 
When a translating ribosome encounters the secondary structure, it is 
forced to pause with its A- and P-site tRNAs over the slippery site (Figure 7B). 
During this pause, the tRNAs that are paired to the slippery site can slip in the 
5’ direction by one base, and re-pair their non-wobble bases to the -1 frame 





the downstream secondary structure has been resolved, the elongating 
ribosome will continue to decode the message reading in the -1 frame (Figure 
7D)102.  
Analysis of the known viral frameshift signals allowed for the creation of 
PRFdb, a database available at prfdb.umd.edu, containing the predicted -1 
PRF signals in 17 eukaryotic genomes101. PRFdb shows that ~10% of genes 
contain predicted -1 PRF signals101. In eukaryotes, cellular -1 PRF events are 
predicted to redirect translating ribosomes to premature termination codons 
(Figure 8A), targeting messages for degradation through the Nonsense-
Mediated mRNA Decay (NMD) pathway (Figure 8B)88,102–104. An inverse 
exponential relationship between the efficiency of -1 PRF and mRNA steady 










Figure 8. -1 PRF signals in eukaryotes functions as mRNA destabilizing 
elements 
(A) Data from PRFdb (-1 PRF database available at prfdb.umd.edu) plotting 
the number of C-terminal extensions (y-axis) and their length in codons (x-axis) 
shows that 99% of -1 PRF events direct the ribosome to a stop codon within 30 
codons. (B) -1 PRF events direct the ribosome to premature termination 
codons, triggering the recruitment of the nonsense mediated mRNA decay 
(NMD) complex to the mRNA. This results in deadenylation and decapping of 
the mRNA, making it a substrate for exonucleolytic degradation. Figure from 









Figure 9. -1 PRF leads to degradation of message through the NMD 
pathway 
Demonstration of the inverse exponential relationship between frameshifting 
efficiency (x-axis) and mRNA abundance (y-axis). Figure from Advani and 
Dinman, 2015106. 
 
Genetic evidence and mathematical modeling indicate that kinetic 
partitioning leading to -1 PRF can occur at three different steps in the  
elongation cycle99,107. A frameshifting event can occur as the ribosome 
translocates into (Figure 10, box 1) or out of (Figure 10, box 3) the slippery 
site, or during accommodation of the aminoacyl-tRNA into the A-site of the 
slippery site (Figure 10, box 2)99,107. The underlying biophysical mechanism 
thorough which -1 PRF is hypothesized to occur is the torsional restraint 
model108. In all three cases, GTP hydrolysis provides energy for unpairing of 






Figure 10. Possible paths to -1 PRF 
-1 PRF can occur at three different times during translation of the slippery site. 
The first is directed by secondary structure as the ribosomes translocates into 
the slippery site. The second is as a result of torsional strain created by 
accommodation of aminoacyl-tRNA into the slippery site. The third path is 
directed by secondary structure as the ribosome translocates out of the slippery 
site. Tension is relieved by base pairing breaking, ribosome slipping in the 5’ 
direction by one base, and base pairing reforming. Figure from Dinman, 201299. 
 
Programmed +1 Ribosomal Frameshifting (+1 PRF) 
Another translational recoding exception is programmed +1 ribosomal 
frameshifting (+1 PRF). As opposed to -1 PRF, the ribosome slips one 
nucleotide in the 3’ direction at the time of a +1 PRF event. A heptameric 
slippery site is also required for +1 PRF events, while the downstream structure 
is optional. In +1 PRF events, ribosomal pause can be caused by either rare 
codons requiring rare, low abundance cognate tRNAs, or downstream 
secondary structures109,110. Messages requiring a +1 PRF event have been 
described in viruses, bacteria, yeast, and mammalian cells109–113. The OAZ1 
+1 PRF signal, conserved from yeast to humans, is the most well-studied. 





feedback mechanism between the amount of polyamines in the cell and the 
level of frameshifting in the OAZ1 mRNA109,112. 
 
Missense and termination codon (nonsense) suppression 
Other forms of translational recoding are due to ribosome decoding 
errors. Missense suppression occurs when the ribosome incorporates either a 
near- or non-cognate amino acid in place of the amino acid that was encoded 
in the mRNA. This is sometimes due to scarcity of the amino acid, just like +1 
PRF. Nonsense suppression takes place when the ribosome incorporates a 
suppressor tRNA, as opposed to a release factor, at a termination codon. This 
causes the ribosome to continue decoding the mRNA past the stop codon. This 
mechanism is used by some viruses to translate gag-pol fusion proteins114,115 
and by in all organisms to encode selenocysteine, the 21st amino acid116–118. 
 
Translational fidelity reporters 
Translational fidelity profiles are often assayed in living cells through the 
use of dual reporter plasmids119–121. In this project, dual luciferase reporters 
were used. The control zero frame readthrough reporter contains Renilla and 
firefly luciferases in the zero frame (Figure 11A). Dual luciferase reporters used 
to monitor rates of -1 PRF, +1 PRF, and nonsense suppression contain Renilla 
in the zero frame, followed by a test sequence in such a way that firefly 
luciferase is in the -1, +1, and zero frames, respectively (Figure 11B). 





recoding event takes place firefly luciferase will also be translated. To monitor 
rates of missense suppression, the firefly luciferase of the zero frame 
readthrough control was mutated (either near- or non-cognate as indicated, 
Figure 11C) in the catalytic site. While a fusion protein will always be 
translated, firefly luciferase will only be catalytically active if the ribosome 
misincorporates arginine at residue 218 (Figure 11C). Translational recoding 
is calculated as a ratio of ratios (Figure 11D)119,122. 
 
Figure 11. Dual luciferase reporters used to measure translational 
recoding 
(A) Zero frame readthrough control contains Renilla and firefly luciferases in 
the zero frame. (B) Dual luciferase reporters used to monitor rates of -1 PRF, 
+1 PRF, and nonsense suppression contain Renilla in the zero frame, and 
firefly luciferase in the indicated frame. (C) Dual luciferase reporter to measure 
missense suppression contains Renilla and firefly luciferases in the zero frame, 
and the firefly luciferase contains mutations at arginine 218 in the catalytic site. 
The near- and non-cognate mutations are listed. Only when the ribosome 
mistranslates and incorporates an arginine the firefly luciferase is catalytically 
active. (A-C) Zero frame and translationally recoding products are indicated. 
(D) Translational recoding is calculated as a ratio of ratios. Figure from Paolini 







In this research program, we investigate the specialized ribosomes vs. 
gene dosage hypotheses. It is known that ribosome biogenesis defects are 
present in cells carrying mutations that lead to ribosomopathies. We 
endeavored to fill gaps in knowledge regarding ribosome translational fidelity 
in these cells. Our data suggests that gene dosage explains the defects 
observed in yeast pseudo-haploinsufficient models. Changes in termination 
codon suppression were observed in ribosomopathy patient-derived cells. We 
also showed that ribosomopathies pre-adapt the cells for handling stress. We 
acknowledge the limitation on the use of yeast as a model organism. While the 
yeast allowed us to genetically mimic the patients’ ribosomal 
haploinsufficiency, the yeast are unicellular organisms with very little 
developmental biology. Whether specialized ribosomes may help explain 









Chapter 2: Materials and Methods 
 
Preparation of plasmid DNA 
Small scale preparation of DNA was done using GeneJET Plasmid 
Miniprep Kit (Thermo Scientific, catalog # K0503), according to manufacturer’s 
instructions. Large scale preparation of plasmid DNA was done using either 
Qiagen Plasmid Plus Midi Kit (Qiagen, catalog # 12943) or ZymoPURE™ II 




NEB® 5-alpha competent E. coli 
Between 30 and 50 µl of NEB® 5-alpha competent E. coli cells (NEB, 
catalog # C2988J) were thawed on ice and mixed with 500 ng of plasmid DNA 
(1-5 µl). Mixtures were pipetted up and down to mix, and incubated on ice for 
30 minutes. Samples were then heat shocked at 42°C for 30 seconds, and 
placed on ice for 5 minutes. Room temperature SOC was added to the mixture 
to bring the volume up to 1 ml. Cells were allowed to grow for 60 minutes 
shaking at 37°C. One hundred µl of the mixture was plated on LB with 100 






Stellar™ Competent Cells 
Between 30 and 50  µl of Stellar™ competent cells (Clontech, catalog # 
636766) were thawed on ice and mixed with 2 µl In-Fusion reaction mixture 
(from TaKaRa’s In-Fusion® HD Cloning Kit, catalog # 639650). Mixtures were 
pipetted up and down to mix, and incubated on ice for 30 min. Samples were 
then heat shocked at 42°C for 45 seconds, and placed on ice for 2 minutes. 
SOC at 37°C was added to the mixture to bring the volume up to 500 µl. Cells 
were allowed to grow for 60 minutes shaking at 37°C. One hundred µl of the 
mixture were plated on LB with 100 μg/ml carbenicillin plates, and incubated 
overnight at 37°C. 
 
Yeast transformations 
Following the lithium acetate method123,124, yeast cultures were grown 
overnight shaking at 30°C in liquid YPAD media to OD600 ≈ 1, and 200-500 µl 
of culture were pelleted, washed with 200 µl of 0.1 M LiOAc/TE buffer, and 
resuspended in 100 µl of the same buffer. These cell suspensions were mixed 
with 15-18 µl of salmon sperm single stranded DNA (50 mg/ml), 500 ng of 
plasmid, and 500 µl of PEG/LiOAc/TE buffer, and incubated at 30°C for 1 hour. 
After a heat shock at 42°C for 7 minutes, the cells were pelleted, washed with 






Generation of UPF1 gene deletion yeast strains 
Generation of disruption cassette 
UPF1 gene deletion strains were created following the protocol 
described by Hegemann et al.125. The disruption cassette was generated by 
PCR amplification from pJD1521 (i.e. pUG73126) using DreamTaq PCR Master 
Mix (Thermo Fisher Scientific, catalog # K1071) using the following primers: 
OL5’ for KO yUPF1 and OL3’ for KO yUPF1 v2 (sequences can be found in 
Appendix 4). These primers contain ~20 nucleotides that are complementary 
to pJD1521, and 45 nucleotides that are complementary to flanking regions of 
the UPF1 gene. The thermocycling conditions were as follows: 1: 95°C for 5 
minutes, 2: 95°C for 90 seconds, 3: 58°C for 50 seconds, 4: 72°C for 150 
seconds, 5: steps 2-4 were repeated 29 times, 6: 72°C for 15 minutes. The 
PCR product is expected to be 2,518 base pairs consisting of 45 base pairs at 
either end complementary to flanking regions of UPF1 gene, and internal 2,428 
base pairs with the LEU2 coding region. The PCR product was resolved on a 
1.5% agarose gel stained with ethidium bromide, and product was excised and 
purified using GeneJET Gel Extraction Kit (Thermo Fisher Scientific, catalog # 
K0691), according to manufacturer’s instructions. 
 
Yeast transformation 
Yeast strains yJD1524 (ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 
ura3-1 cbf5::TRP1 + CBF5 on pRS313) and yJD1525 (ade2-1 can1-100 his3-





transformed with LEU2 cassette as described above, and plated on –leu media 
plates. 
 
Verification of gene disruption by PCR 
To verify if the UPF1 gene had been successfully disrupted, colony PCR 
was carried out using DreamTaq PCR Master Mix (Thermo Fisher Scientific, 
catalog # K1071) using the following pairs of primers: A and B-M, C-M and D, 
A and B, C and D, and A and D (sequences can be found in Appendix 4). The 
thermocycling conditions were as follows: 1: 95°C for 7 minutes, 2: 95°C for 90 
seconds, 3: 50°C for 120 seconds, 4: 72°C for 150 seconds, 5: steps 2-4 were 
repeated 34 times, 6: 72°C for 15 minutes. The resulting yeast strains were 
named yJD1745 (ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 ura3-1 
cbf5::TRP1 + CBF5 on pRS313) and yJD1746 (ade2-1 can1-100 his3-11 leu2-
3, 112 trp1-1 ura3-1 cbf5::TRP1 + CBF5 D95A on pRS313). 
 
CBF5 RNA-Seq experiments 
RNA extraction and cDNA sequencing 
First experiment. Yeast cultures were grown overnight in YPAD media 
(yJD1524: 1 night, yJD1525: 2 nights) shaking at 30°C. Samples were 
backdiluted to OD600 ≈ 0.8, and allowed to grow for 2 hours 30 minutes. Cells 
in 5 ml of media were pelleted at 4,000 x g for 2 minutes. Cell pellets were 
resuspended in 1 ml of TRIzol ® Reagent (Ambion, catalog # 15596018), and 





were added to each sample. Samples were vortexed for 30 minutes at 
maximum speed at 4 ˚C. Samples were then centrifuged at 20,000 x g for 1 
minute at 4˚C to clear lysate and settle zirconia beads. The 1 ml of supernatant 
from each sample was transferred into a clean microcentrifuge tube, and 200 
µl of chloroform were added. Each tube was inverted 6 times, and incubated at 
room temperature for 3 minutes. Samples were centrifuged at 10,000 x g for 
25 minutes in the cold room. The upper aqueous layer from each sample was 
transferred to a clean microcentrifuge tube, and 700 µl of cold 100% iso-
propanol (Sigma-Aldrich, catalog # I9516-500ML) were added to each. 
Samples were incubated overnight at -20°C. RNA was then pelleted at 10,000 
x g for 20 minutes. The supernatant was discarded and 1 ml of cold 75% 
ethanol (prepared from absolute ethanol, Pharmco-Aaper, catalog # 
111000200, and nuclease-free water) was added to each sample. RNA was 
pelleted at 10,000 x g for 5 minutes, and supernatants discarded. The RNA 
pellets were washed a second time with 75% ethanol, air dried, and 
resuspended in 88 µl of nuclease-free water, 10 µl of 10X TURBO DNase buffer 
(Ambion, catalog # 4022G) and 2.5 µl of TURBO DNase (Ambion, catalog # 
2238G2). Samples were incubated at 37°C for 30 minutes. To each sample, 15 
µl of DNase inactivation reagent (Ambion, catalog # 8174G) were added. Tubes 
were flicked to mix every minute during a 5 minute incubation at room 
temperature. Samples were then centrifuged at 20,000 x g at room temperature 
for 1 minute. Each supernatant was transferred to a fresh tube, and 10 µl of 3 





(Pharmco-Aaper, catalog # 111000200) were added. Samples were incubated 
overnight at -80°C, and then pelleted at 20,000 x g for 20 minutes in the cold 
room. Supernatants were discarded, and pellets were resuspended in 1 ml of 
75% ethanol (prepared from absolute ethanol, Pharmco-Aaper, catalog # 
111000200, and nuclease-free water). Samples were pelleted at 20,000 x g for 
15 minutes. Supernatants were discarded, RNA pellets were air dried, and 
resuspended in 50 µl of nuclease-free water. 
 
Second experiment (2 batches). Yeast cultures were grown overnight in 
YPAD media (yJD1524 and yJD1745: 1 night, yJD1525 and yJD1746: 2 nights) 
shaking at 30°C. Samples were backdiluted to OD600 ≈ 0.8, and allowed to grow 
for 2 hours 30 minutes. Cells in 3 ml of media were pelleted at 4,000 x g for 2 
minutes. RNA was isolated using UltraClean® Microbial RNA Isolation Kit (Mo 
Bio, catalog # 15800-50) and On-Spin Column DNase I Kit (Mo Bio, catalog # 
15100-50) according to manufacturer’s instructions. 
 
All experiments (3 batches). After DNase treatment, the RNA was further 
purified using the Qiagen RNeasy mini kit (Quiagen, catalog # 74104), poly(A)+ 
RNA was selected using oligo-dT following Illumina TruSeqv2 instructions and 
its integrity was assessed using an Agilent 2100 bioanalyzer. cDNA libraries 
were constructed using a TruSeq RNA Sample prep Kit Version II (Illumina, 





were sequenced on an Illumina HiSeq 1500 at the UMD Next Generation 
Sequencing Core / IBBR DNA Sequencing Facility. 
 
Data quality assessment and visualization 
Quality assessment of 50 nucleotide single-end reads was preformed 
via an initial evaluation with FastQC 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and biopieces 
(https://biopieces.org). Illumina sequencing adapters and low quality 
sequences were removed with Trimmomatic127. The remaining sequences 
were mapped against the S288C strain of Saccharomyces cerevisiae using the 
Ensembl S. cerevisiae release 64 genome and annotation data 
(ftp://igenome:G3nom3s4u@ussd-
ftp.illumina.com/Saccharomyces_cerevisiae/Ensembl/R64-1-
1/Saccharomyces_cerevisiae_Ensembl_R64-1-1.tar.gz). Alignments were 
done using Bowtie 2128 version 2.1.0. Alignments were compressed, sorted, 
and indexed using samtools129 and counted against the set of annotated 
transcripts using HTSeq130. Example scripts and all tables resulting from 
analyses are available in an online repository at 
https://github.com/cmsvieira/scerevisiae_cbf5. The resulting count tables were 
passed to R for outlier testing, sample clustering, visualization, and differential 
expression analyses with the hpgltools package (http://github.com/elsayed-





available as Datasets E1_written_20180606.xlsx and 
E1E2_written_20180212.xlsx in the online repository. 
 
Differential expression and gene ontology analyses 
Samples were tested for significant outliers using a mix of hierarchical 
clustering and principal component analysis. Non-expressed and weakly 
expressed genes, defined as having <2 reads per million in n of the samples, 
where n is the size of the smallest group of replicates, were removed prior to 
differential expression (DE) analysis. Multiple data normalization methods were 
tested, including a mix of: quantile, log transformation, and counts per million. 
Surrogate variables / batches were queried with a mix of methods from sva131 
to ruv132. The first batch of the second experiment was an outlier and was 
removed from further analysis (discussed in chapter 3). The removed batch 
contained samples hpgl0774 through hpgl0781, resulting in a total of 6 samples 
of CBF5 UPF1 (hpgl0564 through hpgl0567, hpgl0782, and hpgl0786), 6 
samples of cbf5-D95A UPF1 (hpgl0568 through hpgl0571, hpgl0783, and 
hpgl0787), 2 samples of CBF5 upf1Δ (hpgl0784, and hpgl0788), and 2 samples 
of cbf5-D95A upf1Δ (hpgl0785, and hpgl0789) for analyses. Differential 
expression analyses were performed and compared using surrogate estimates 
from sva with limma133, DEseq2134, EdgeR135, and a statistically uninformed 
basic method as a diagnostic control. Genes were considered ‘significant’ when 
the DEseq2 observed |log2 fold-change| was equal or greater than 1.0 





genes for each contrast of interest was passed to g:Profiler136 through its R 
interface. 
 
Translational fidelity: Dual luciferase assays 
Yeast 
Reporters. pJD376 (pYDL-LA)119, pJD1018 (pYDL-EST2)104, pJD1039 
(pYDL-STN1)104, and pJD1041 (pYDL-EST1)104 were used to monitor rates of 
-1 PRF. Rates of +1 PRF were assayed using pJD377 (pYDL-EST3)119. 
pJD431 (pYDL-UAA), pJD432 (pYDL-UAG), and pJD433 (pYDL-UGA) were 
used to assay termination codon readthrough119,137. Suppression of an AGC 
near-cognate serine codon or a TCT non-cognate serine codon in the firefly 
luciferase catalytic site was assayed using pJD642 (pYDL-TCT218), and 
pJD643 (pYDL-AGC218)138,139. pJD375 (pYDL-control)119 was used as the zero 
frame dual luciferase reporter. All assays were performed in triplicate a 
minimum of three independent times.  
Yeast transformations by lithium acetate method were carried out as 
described above. Transformants were plated on –ura plates, since dual 
luciferase reporters contain the URA3 gene.  
 
Sample preparation of RPS23A strains. Transformed yeast cultures 
were grown overnight shaking at 30°C in H-tryptophan-uracil liquid media 
containing galactose and raffinose, and after 24 hours media was replaced with 





backdiluted to OD600 = 0.5 and allowed to grow for 2 hours shaking at 30°C. 
Cells were pelleted by centrifugation, washed with phosphate buffered saline 
(PBS), and resuspended in PBS with 1mM phenylmethylsulfonylfluoride 
(PMSF). Glass beads (0.5 mm) were added to the cell suspensions, and 
samples were lysed on a bead-beater for 2 minutes or vortexed at max speed 
for 10 minutes. Twenty µl of supernatant were placed on a white 96-well plate 
for assay.  
 
Sample preparation of ohnolog deletion and duplication strains. 
Transformed yeast cultures were grown overnight shaking at 30°C in –ura liquid 
media. Samples were backdiluted to OD600 = 0.4 and allowed to grow for 2 
hours shaking at 30°C. Ninety µl of 1X Passive Lysis Buffer (PLB) (Pomega) 
and 10 µl of culture were combined on each well of a white 96-well plate, and 
assayed.  
 
Mammalian cell lines 
All DBA and MacInnes patient-derived cell lines listed below were kindly 
provided by Dr. Alyson MacInnes at euroDBA, and were deidentified by the 
providers. 
Reporters for MacInnes Syndrome project. pJD2046 (pHDL-fullCMV-
UAA)68 was used to monitor termination codon readthrough. pJD2044 (pHDL-
fullCMV-control)68 was used as the zero frame dual luciferase reporter. To 





the pCDNA3.1(+) plasmid template using the following oligonucleotide primers: 
CMVprom-forward and CMVprom-reverse (sequences can be found in 
Appendix 4). Primers were designed to have either Kpn I or Pst I restriction 
enzyme digest sites so that PCR amplicons could be digested and ligated into 
similarly digested pJD175f (pHDL-SV40-control)105, and pJD1643 (pHDL-
SV40-UAA)100 dual luciferase reporter plasmids. 
 
MacInnes Syndrome project. Deidentified fibroblasts (RPS23-F120I and 
RPS23-R67K were MacInnes Syndrome patient-derived cell lines, and C109 
and 9E0872 were used as healthy controls) were transfected by electroporation 
using a Nucleofector II apparatus (Amaxa™) and the Amaxa™ Normal Human 
Dermal Fibroblasts Nucleofector kit (Lonza, catalog # VPD-1001), per the 
manufacturer’s instructions. For each transfection, 4-5x105 cells were mixed 
with 3 µg of plasmid DNA. All assays were performed in triplicate a minimum 
of 3 times. 24 hours post-transfection,  cell lysates were prepared using passive 
lysis buffer (Promega) and luciferase activities were determined using the Dual-
Luciferase® Reporter Assay System (Promega, catalog # E1960), per the 
manufacturer’s instructions. 
 
Reporters for DBA project. A new generation of dual luciferase reporters 
was generated by Loughran, et al. to correct interference of test sequence with 
stability and activity of Renilla and firefly luciferases121. Plasmid pSGDluc, 





sequence121, was kindly provided by Dr. John Atkins, at University College 
Cork. In order to disrupt the Bam HI/Sal I sites present downstream of the firefly 
luciferase coding sequence, complimentary oligonucleotides (BamSalKilT and 
BamSalKilB, sequences in Appendix 4) were ligated with linearized vector. The 
resulting plasmid was doubly digested with Xho I and Apa I, and the vector 
portion was used in Gibson assembly. A gBlock (sequence in Appendix 4) was 
used to insert the HIV -1 PRF signal98,140 between new Sal I and Bam HI sites. 
After sequence verification, the resulting plasmid (pJD2256) was linearized 
with BamHI and SalI, and another set of complementary oligonucleotides 
(Alphahelixspacer-T2 and Alphahelixspacer-B2, sequences in Appendix 4) was 
used to insert an alpha helix spacer which creates an open reading frame 
encoding the peptide sequence: EAAAKEAAAKA. The resulting plasmid, 
pJD2257, was used as the zero frame dual luciferase reporter. pJD2337 
(PEG10) was used to monitor -1 PRF, and pJD2349 (OAZ1) was used to 
monitor +1 PRF. pJD2443 (UAA), pJD2444 (UGA), and pJD2445 (UAG) were 
used to monitor stop codon readthrough. To make the constructs used to 
monitor PEG10141,142 and OAZ1109 mediated -1 and +1 PRF, a gBlock was 
inserted in linearized pJD2257 by Gibson Assembly (sequences in Appendix 
4). To make the constructs used to monitor stop codon readthrough, sets of 







DBA project. Deidentified lymphoblast cell lines (RPL9 L20P (C.I.), and 
RPL9 c.-2+1 were DBA patient-derived cell lines, and F.T., NhnF, and NhnM 
were used as healthy controls) were transfected by electroporation using a 
Nucleofector II apparatus (Amaxa™) and the Amaxa™ Cell Line Nucleofector® 
Kit V (Lonza, catalog # VVCA-1003), per the manufacturer’s instructions. For 
each transfection, 1.5 x 106 cells were mixed with 1.5 µg of plasmid DNA. All 
assays were performed in triplicate four times. Cell lysates were prepared using 
passive lysis buffer (Promega) and luciferase activities were determined using 
the Dual-Luciferase® Reporter Assay System (Promega, catalog # E1960), per 
the manufacturer’s instructions 24 hours post-transfection. 
 
Data analysis  
Data were analyzed by taking the ratio of firefly luciferase to Renilla 
luciferase for each of the plasmids normalized to the same ratio obtained from 
the readthrough plasmid control in the same experiment. Data were plotted on 
GraphPad Prism as percent translational recoding, with each symbol 
representing one biological sample assayed in triplicate. Error bars represent 
standard deviation.  
  
Cell culture 
Deidentified patient-derived fibroblasts and lymphoblast cell lines (LCLs) 
mentioned above, as well as healthy control cell lines were generously provided 





foundation (euroDBA). Adherent cell lines (i.e. fibroblasts) were grown using 
Dulbecco's Modification of Eagle's Medium (DMEM, Corning, catalog # 10-013-
CV) supplemented with 30% Fetal Bovine Serum (FBS, Gibco, catalog # 
10437-028) and 1% penicillin/streptomycin (Gibco, catalog # 15140-122). 
Suspension cell lines (i.e. LCLs) were grown in Roswell Park Memorial Institute 
medium (RPMI, Lonza, catalog # 12-115F) supplemented with 30% FBS, 1% 
L-glutamine, and 1% penicillin/streptomycin. Cell lines were maintained in a 
humidified incubator at 37°C with 5% CO2.  
 
Growth curve experiments 
Yeast cultures were grown overnight shaking at 30°C (1 day for 
yJD1524, 2 days for yJD1525). Cells were then backdiluted to OD600 = 0.05 
with YPAD media to a final volume of 500 µl, in a 12-well clear plate. Growth 
was monitored for 47 hours in a BioTek Synergy HT microplate reader at 30°C, 
with readings taken every hour, after samples were shaken for one minute. 
Data were analyzed on Excel and growth curves made on GraphPad. 
   
Reactive oxygen species: Amplex® Red assay 
All experiments were carried out using Amplex® Red Hydrogen 
Peroxide/Peroxidase Assay Kit (Invitrogen cat# A22188), according to 
manufacturer’s instructions with some modifications143,144. Wild-type yeast cells 





hours. Readings for OD595 were collected every hour, after 1 minute of shaking. 
cbf5-D95A cells (yJD1525) were grown the same way for 42 hours. Knowing 
that 1 unit of OD600 corresponds to ~ 3 x 107 yeast cells, 2 x 107, 4 x 107, and 
8 x 107 yeast cells were transferred into microcentrifuge tubes, and pelleted at 
4,000 x g for 3 minutes. The cell pellets were resuspended in 500 µl of 1X 
Reaction buffer, incubated for 1 h shaking at 30°C. After that time, 100 µl of 
each sample were loaded in quadruplicate on a 96-well plate. To each well, 
100 µl of 100 µM Amplex® Red reagent and 0.2U/ml HRP solution were added, 
and the sample incubated in the dark for 30 minutes. After that time, the 
fluorescence was measured in a Glomax Multi + Detection System (Promega) 
using the green filter (absorbance: 525 nm and emission: 580-640 nm). A 
standard curve was developed from samples of hydrogen peroxide (H2O2) 
dissolved at different concentrations in 1X Reaction Buffer. Final 
concentrations of H2O2 in the standard curve were 0, 0.015625, 0.03125, 
0.0625, 0.125, 0.25, 0.5, 1, 2, 3, 4, and 5 µM.  
 
Data analysis 
Data for the wells without any cells or H2O2 was averaged and 
subtracted from every reading as background. Corrected duplicate readings of 
the H2O2 samples were averaged to plot a standard curve. Quadruplicate cell 
sample readings were averaged. Final H2O2 concentration in the well was 
calculated from the standard curve, and doubled to find the H2O2 concentration 





and each plotted as a single point on the graph, along with mean and standard 
deviation, using GraphPad Prism. 
 
Tunicamycin sensitivity assay 
CBF5 strains 
Yeast cultures (yJD1524 and yJD1525) were grown overnight in YPAD 
media shaking at 30°C. OD600 was taken, and samples backdiluted to OD600 = 
0.6, and allowed to grow for 2 hours 30 minutes. Samples were diluted to OD600 
= 0.1, and 10-fold serial dilutions were made, plated on YPAD plates containing 
either 0, 0.25, 0.5, or 1 µg/ml tunicamycin, and allowed to grow at 30°C. 
Photographs of the plates were taken daily. 
 
Haploinsufficiency strains 
Yeast cultures (yJD1732, 1739-1744, 1753-1754, and 1756-1760) were 
grown overnight in YPAD media shaking at 30°C. OD600 was taken, and 
samples backdiluted to OD600 = 0.6, and allowed to grow for 2 hours 30 
minutes. Samples were diluted to OD600 = 0.1, and 10-fold serial dilutions were 
made, plated on YPAD plates containing either 0, 0.25, 0.5, or 1 µg/ml 








Yeast cultures (yJD1729-1731) were grown overnight in –trp media 
containing galactose and raffinose shaking at 30°C. Media was replaced with 
–trp media containing dextrose 24 hours before the assay. OD600 was taken, 
and samples backdiluted to OD600 = 0.6, and allowed to grow for 2 hours 30 
minutes. Samples were diluted to OD600 = 0.1, and 10-fold serial dilutions were 
made, plated on –trp plates containing dextrose, and either 0, 0.25, 0.5, or 1 
µg/ml tunicamycin, and allowed to grow at 30°C. Photographs of the plates 
were taken daily. 
   
HAC1 mRNA splicing 
Treatment with tunicamycin 
CBF5. Yeast cultures (yJD1524-1525) were grown overnight in YPAD 
media shaking at 30°C. OD600 was taken, and samples backdiluted to OD600 = 
0.3, and allowed to grow for 1 hours 30 minutes shaking at 30°C. One µg/ml 
tunicamycin was added, and samples incubated for 1 hour shaking at 30°C.  
RPS23. Yeast cultures (yJD1729-1731) were grown overnight in –trp 
media containing galactose and raffinose shaking at 30°C. Media was replaced 
with –trp media containing dextrose 24 hours before the assay. OD600 was 
taken, and samples backdiluted to OD600 = 0.3, and allowed to grow for 1 hours 
30 minutes shaking at 30°C. One µg/ml tunicamycin was added, and samples 





RNA isolation and cDNA synthesis 
OD600 was determined, and 1x107 yeast cells were collected after the 1 
hour incubation with tunicamycin. RNA was isolated using Direct-zol™ RNA 
MiniPrep Plus kit (Zymo, catalog # R2072), according to manufacturer’s 
instructions. cDNA was synthesized from 450 ng of RNA using iScript cDNA 
Synthesis Kit (Bio-Rad, catalog # 1708891), according to manufacturer’s 
instructions. 
 
PCR to determine HAC1 mRNA splicing status 
Primers used were obtained from the literature145, and the sequences 
are listed in Appendix 4. The PCR master mix contained 1X DreamTaq PCR 
MasterMix, 1 µM each of forward and reverse primer, and 2 µl of 1:10 cDNA 
dilution. The thermocycling conditions were as follows: 1: 95°C for 3 minutes, 
2: 95°C for 30 seconds, 3: 58°C for 30 seconds, 4: 72°C for 60 seconds, 5: 
steps 2-4 were repeated 35 times, 6: 72°C for 15 minutes. The PCR products 
were resolved on a 1.5% agarose gel stained with ethidium bromide. Unspliced 
HAC1 mRNA is 363 bases, and the spliced HAC1 mRNA is 111 bases. rRNA 






Chapter 3: Yeast models of X-DC, DBA, ICA, and 5q- 
Syndrome suggest that metabolic imbalances pre-
adapt cells to stressors 
 
Introduction 
Ribosomopathies are a class of diseases caused by mutations in 
ribosomal proteins or ribosome biogenesis factors. As discussed in chapter 1, 
haploinsufficiency for these proteins has been shown to impart ribosome 
biogenesis defects in patient-derived cells and in ribosomopathy model 
systems. These defects were either in the small or large subunit depending on 
which ribosomal protein was mutated. 
As discussed in detail in chapter 1, while most ribosomopathies present 
with anemia, they each have their own unique set of symptoms. A specialized 
ribosomes hypothesis has been formulated on the basis of these unique 
symptoms20,29,146,147. A study of Rpl38 (eL38) mutant mouse embryos with 
homeotic transformations revealed that Rpl38 transcripts were enriched in a 
tissue-specific manner in mice. Higher expression of Rpl38 transcripts was 
detected in embryonic regions where the Ts/+ phenotype (characterized by a 
short and kinky tail and cleft palate) was observed. eL38 (as part of the 
ribosome) was shown to facilitate formation of 80S complex during translation 
initiation on some specific Hox mRNAs (the same ones that appeared as part 





Further studies are required to determine if heterogeneity of ribosomal proteins 
confers ribosomes “specialized” activity.   
An alternative explanation posits that ribosomopathies are due to 
metabolic imbalance in the cells 149–151. Supporters of this theory suggest that 
the mutations implicated in ribosomopathies lead to a lower concentration of 
ribosomes in the cells149. Lower ribosome concentrations can differentially 
affect translation of messages depending on rates of translation initiation149,152. 
GATA1 has been used as an example to illustrate the effects of the rates of 
translation initiation. GATA1 encodes a transcription factor involved in erythroid 
differentiation36, and mutations in this gene have been implicated in DBA36,43. 
GATA1 mRNA has a highly structured region at the end of its 5’ UTR153. This 
renders GATA1 more sensitive to lower ribosome concentration and resulting 
changes in rates of translational initiation149,153.  
A yeast cbf5-D95A mutant originally developed by the laboratory of Dr. 
John Carbon66 was subsequently re-engineered in the Dinman lab 100,154. Cells 
harboring the cbf5-D95A mutation show decreased rRNA pseudouridylation 
content 66. This results in production of ribosomes that have lower affinity for 
tRNAs both at the A- and the P-sites154. This in turn allows tRNAs to more 
readily slip along mRNAs, leading to increased rates of -1 PRF in yeast, in a 
dkc1m hypomorphic mouse model, and in HeLa cells in which DKC1 was 
knocked down by use of an siRNA154. Yeast cells carrying the cbf5-D95A 
mutation show hyperaccurate recognition of termination codons, consistent 





tRNAs (e.g. for suppressor tRNAs)154. It has also been determined by qRT-
PCR that messages that contain -1 PRF signals are less abundant in cbf5-
D95A cells than in WT cells100. This is likely due to the synergistic effects of 
increased levels of -1 PRF, which leads ribosomes to premature termination 
codons, and the increase in recognition of termination codons, which would 
lead to more efficient recruitment of the NMD complex and consequent 
degradation of the messages containing -1 PRF signals.  In addition, cbf5-
D95A cells have also been shown to have shorter telomeres than those present 
in WT cells100, consistent with the progeria phenotype associated with X-
DC155,156. In the current work, we have employed this system as a model of X-
DC. 
As diploid organisms, humans harbor two alleles of each of the 
ribosomal protein genes within their genome. In contrast, laboratory yeast 
strains are haploid. However, these yeast strains harbor two versions (A and 
B, called ohnologs) of most of the ribosomal protein genes as a result of a 
historical whole genome duplication event69. In the current study, we have 
capitalized on this to create pseudo-haploinsufficient yeast models of DBA 
(RPS19 deletion since it is most commonly mutated in DBA patients), ICA 
(RPS0, which encodes uS2), and 5q- Syndrome (RPS14) by deleting one of 
the ribosomal protein gene ohnologs. Control yeast ohnolog duplication strains 
(kindly provided by Dr. Sherif Abou Elela at the University of Sherbrooke) 
harbor a second copy of the undeleted ribosomal protein ohnolog inserted into 





determine, in yeast, whether translational fidelity differences were due to the 
ribosomal protein ohnolog that the cells were lacking or due to lower expression 
of the ribosomal protein.  
The goals of the experiments in this chapter were to: 1) contribute to 
addressing the question of whether ribosomopathies are due to specialized 
ribosomes or gene dosage, 2) determine gene expression profile of yeast 
model of X-DC, and 3) investigate sensitivity to stress in yeast models of the 
ribosomopathies described here, i.e. X-DC, DBA, ICA, and 5q- Syndrome. 
 
Results 
Translational fidelity defects in yeast models of ribosomopathies resulting from 
haploinsufficiency of ribosomal proteins are due to gene dosage effects 
In an effort to contribute to the specialized ribosomes or gene dosage 
dialogue146,149, the translational fidelity profiles of the yeast models of DBA, 
ICA, and 5q-Syndrome, as well as of the control ohnolog duplication strains 
were determined. In order to monitor translational fidelity in these cells, dual 
luciferase reporters (described in chapter 1, Figure 11) were used to assay 
levels of -1 and +1 PRF, as well as nonsense and missense suppression. For 
this, each of the model yeast and control ohnolog duplication strains were 
transformed with a suite of dual luciferase reporter plasmids, and assayed 





Rates of -1 PRF were measured with a reporter containing the L-A 
frameshift signal89. Ohnolog-specific effects on -1 PRF were observed upon 
deletion of single ohnologs.  In one case -1 PRF was enhanced (rps0bΔ), in 
others it was decreased (rps0aΔ, rps14bΔ, rps19aΔ, and rps19bΔ), and in one 
case it remained unchanged (rps14aΔ) (Figure 12A-C). However, replacement 
of the deleted gene with a duplicated ohnolog corrected all -1 PRF defects 
(Figure 12D-F). 
 
Figure 12. Programmed -1 Ribosomal Frameshifting promoted by the L-A 
signal in yeast models of haploinsufficiency 
Rates of -1 PRF promoted by L-A in (A) rps0Δ, (B) rps14Δ, (C) rps19Δ, (D) 
RPS0 duplication, (E) RPS14 duplication, and (F) RPS19 duplication strains. 
Each point represents an experimental replicate performed in triplicate.  A 
minimum of 3 biological replicates were assayed in triplicate for each 
combination of yeast strain and plasmid. One-way ANOVA was used to 
determine significance: * p<0.05, and ** p<0.01. 
 
Rates of +1 PRF were assayed with a dual luciferase reporter containing 





observed between any of the ohnolog deletion strains and the WT, or between 
the ohnolog duplication strains and the isogenic WT (Figure 13).  
 
 
Figure 13. Programmed +1 Ribosomal Frameshifting promoted by the Ty1 
signal in yeast models of haploinsufficiency 
Rates of +1 PRF promoted by Ty1 in (A) rps0Δ, (B) rps14Δ, (C) rps19Δ, (D) 
RPS0 duplication, (E) RPS14 duplication, and (F) RPS19 duplication strains. 
Each point represents an experimental replicate performed in triplicate. A 
minimum of three biological replicates were assayed in triplicate for each 
combination of yeast strain and plasmid. One-way ANOVA did not find any 
statistically significant differences. 
 
Stop codon readthrough was measured using reporters in which each 
of the stop codons was inserted in frame between Renilla and firefly luciferases 
in the zero frame100. No changes in UAA stop codon readthrough were 
observed in the ohnolog deletion strains (Figure 14), and thus UAA stop codon 







Figure 14. UAA stop codon readthrough in yeast models of 
haploinsufficiency 
Rates of UAA stop codon readthrough in (A) rps0Δ, (B) rps14Δ, and (C) rps19Δ 
strains. Each point represents an experimental replicate performed in triplicate. 
A minimum of four biological replicates were assayed in triplicate for each 
combination of yeast strain and plasmid. One-way ANOVA did not find any 
statistically significant differences. 
 
Ohnolog-specific effects on UAG stop codon readthrough were 
observed upon deletion of single ohnologs.  In two cases UAG stop codon 
readthrough was enhanced (rps0bΔ, and rps14aΔ), and unchanged in all 
others (Figure 15A-C). Again however, replacement of the deleted gene with 







Figure 15. UAG stop codon readthrough in yeast models of 
haploinsufficiency 
Rates of UAG stop codon readthrough in (A) rps0Δ, (B) rps14Δ, (C) rps19Δ, 
(D) RPS0 duplication, and (E) RPS14 duplication strains. Each point represents 
an experimental replicate performed in triplicate. A minimum of four biological 
replicates were assayed in triplicate for each combination of yeast strain and 
plasmid. One-way ANOVA was used to determine significance: ** p<0.01. 
 
Ohnolog-specific effects on UGA stop codon readthrough were also 
observed upon deletion of single ohnologs.  In two cases UGA stop codon 
readthrough was enhanced (rps0bΔ, and rps14aΔ), and unchanged in all 
others (Figure 16A-C). However, replacement of the deleted gene with a 







Figure 16. UGA stop codon readthrough in yeast models of 
haploinsufficiency 
Rates of UGA stop codon readthrough in (A) rps0Δ, (B) rps14Δ, (C) rps19Δ, 
(D) RPS0 duplication, and (E) RPS14 duplication strains. Each point represents 
an experimental replicate performed in triplicate.  A minimum of four biological 
replicates were assayed in triplicate for each combination of yeast strain and 
plasmid. One-way ANOVA was used to determine significance: ** p<0.01. 
 
Missense suppression was assayed with reporters in which arginine 218 
in the catalytic site of firefly luciferase was mutated to serine, by either a near-
cognate (AGA  AGC) or non-cognate (AGA  TCT) mutation, rendering it 
catalytically inactive138. Near-cognate missense suppression rate was higher in 
rps0aΔ cells than in WT cells (Figure 17A). This increase was minimal and not 
considered biologically significant. No change in near-cognate missense 
suppression was observed in any of the other five ohnolog deletion strains 







Figure 17. Near-cognate missense suppression in yeast models of 
haploinsufficiency 
Rates of near-cognate missense suppression in (A) rps0Δ, (B) rps14Δ, and (C) 
rps19Δ strains. Each point represents an experimental replicate performed in 
triplicate. A minimum of five biological replicates were assayed in triplicate for 
each combination of yeast strain and plasmid. One-way ANOVA was used to 
determine significance: ** p<0.01. 
 
The rate of non-cognate missense suppression was decreased in two 
cases (rps14bΔ, and rps19bΔ), and remained unchanged in all others (Figure 
18). The observed differences were too small to be considered biologically 
significant. 
 
Figure 18. Non-cognate missense suppression in yeast models of 
haploinsufficiency 
Rates of non-cognate missense suppression in (A) rps0Δ, (B) rps14Δ, and (C) 
rps19Δ strains. Each point represents an experimental replicate performed in 
triplicate. A minimum of six biological replicates were assayed in triplicate for 
each combination of yeast strain and plasmid. One-way ANOVA was used to 






DBA patient-derived lymphoblast cell lines (LCLs) display decreased UAG stop 
codon readthrough 
Lymphoblast cell lines derived from two DBA patients harboring novel 
mutations in the RPL9 gene were also used in this study: RPL9 L20P (C.I.), 
and RPL9 c.-2+1. These deidentified cell lines were obtained from Dr. Alyson 
MacInnes at the euroDBA consortium, who also provided us with three 
deidentified healthy control cell lines: F.T., NhnF, and NhnM. The cells (1.5 x 
106 cells/transfection) were transfected with 1.5 µg of dual luciferase reporter 
plasmid by electroporation. The frameshift signal in PEG10 was used to 
monitor rates of -1 PRF141,142, and that in OAZ1 was used to monitor rates of 
+1 PRF109. No changes in -1 PRF or +1 PRF were observed in either of the 









Figure 19. Rates of -1 and +1 PRF in DBA patient-derived LCLs 
Rates of (A) -1 PRF promoted by PEG10, and (B) +1 PRF promoted by OAZ1 
were measured in DBA patient-derived LCLs and healthy control cell lines. 
Each point represents an experimental replicate performed in triplicate. Four 
biological replicates were assayed in triplicate. 
 
Fibroblasts from patients of another ribosomopathy, MacInnes 
Syndrome, showed differences in UAA stop codon readthrough68. Compared 
to healthy controls, DBA patient 1 carrying RPL9 c.-2+1 mutation displayed a 
decrease in UAG stop codon readthrough, while rates of UAA and UGA stop 
codon readthrough remained unchanged (Figure 20). Patient-derived cells 
tend to have lower Renilla and firefly luciferases activities than established 
commercial cell lines68. The firefly luciferase reads were at times below the 
lower threshold of linear range described in Promega’s dual luciferase kit 
manual. However, stop codon readthrough levels in healthy controls are 






Figure 20. Rates of stop codon readthrough in DBA patient-derived LCLs 
Rates of (A) UAA, (B) UAG, and (C) UGA stop codon readthrough were 
measured in DBA patient-derived LCLs and healthy control cell lines. Each 
point represents an experimental replicate performed in triplicate. Four 
biological replicates were assayed in triplicate. One-way ANOVA was used to 
determine significance: ** p<0.01. 
 
X-DC yeast model cells show specific growth-related phenotype 
Data from the yeast models of haploinsufficiency revealed translational 
fidelity defects, in a manner indicative of a gene dosage effect. This 
engendered the hypothesis that these cells may be stressed because defective 
ribosomes may be causing high levels of mistranslated, and perhaps misfolded 
proteins. We hypothesize that the same is the case in the X-DC cells, where 
translational fidelity defects have been shown in the yeast model (increase -1 
PRF and stop codon recognition154). 
The yeast model of X-DC, cbf5-D95A, has been qualitatively 
characterized as slow growing66. In order to quantify this phenotype, cell growth 
was monitored in 12-well plates, with 500 µl of YPAD media, and allowed to 
grow for 47 hours in a Synergy HT multi-well reader. These data were used to 





longer lag phase in the cbf5-D95A mutant cells (9 hours vs. 4 hours). The wild-
type cells reached log-phase at hour 5, and stationary phase at 18 hours. Once 
cells reached log-phase growth, cell doubling times were determined. Under 
these conditions (samples in 500 µl YPAD in a 12-well plate inside Synergy HT 
chamber, kept stationary at 30°C, with 1 minute of shaking every hour just 
before each measurement was taken), doubling times were determined to be 
2 hours 41 minutes (± 18 minutes) for the WT cells, and 4 hours 38 min (± 35 
minutes) for the cbf5-D95A cells. Notably, the cbf5-D95A mutants remained 
alive in stationary phase for over 10 hours, while the wild-type cells began dying 











Figure 21. Growth curves for CBF5 and cbf5-D95A 
Samples were grown in 500 µl of YPAD media in 12-well plates in a Synergy 
HT plate reader. Chamber was kept at 30°C. Plate was stationary, with 1 
minute of shaking prior to each OD595 measurement taken every hour. N = 10 
biological replicates assayed in 4 independent experiments. OD595 
measurements shown are background subtracted, and an average of each of 
the 10 biological replicates. Doubling times for each individual growth curve 
were calculated and averaged: WT: 2 h 41 min ± 18 min, cbf5-D95A: 4 h 38 
min ± 35 min. 
 
Cellular stress response is elevated in cbf5-D95A cells 
While the cbf5-D95A allele is known to confer translational fidelity 
defects, the effects of reduced rRNA pseudouridylation on global gene 
expression remain uncharacterized. An RNA-Seq analysis was carried out on 
isogenic wild-type CBF5 and cbf5-D95A yeast strains to address this. There 
were two goals for data analyses: 1) determine genes and pathways that are 
differentially expressed in cbf5-D95A cells, and 2) identify messages containing 





RNA was isolated from four biological replicates of each strain, and 
library preparation and Illumina sequencing was performed by the University of 
Maryland Next Generation Sequencing Core / IBBR DNA Sequencing Facility. 
RNA-Seq data were analyzed with the help of Dr. Ashton Trey Belew. The total 
number of reads generated from all libraries is displayed in Appendix 5 (Figure 
34). Mapped sequencing data derived from all libraries were analyzed using a 
variety of methods, including principal component analysis (PCA) and 
hierarchical clustering to inspect the relationships between samples. The 
resulting PCA plot and heat maps (Figure 35) showed the expected clustering 
between biological replicates, and no outliers were identified. Following 
normalization, PCA plot analyses revealed that samples clustered by condition 







Figure 22. Principal component analyses plot of RNA-Seq data shows 
data clustering by condition 
Principal Component Analyses (PCA) plot of RNA-Seq data generated from the 
libraries mapped to the S. cerevisiae genome following removal of rRNA/tRNA 
features. The data was log2(quantile(cpm(filter))) normalized and strong 
clustering by condition is evident in the plot. Each sample is color coded by 
condition/strain. 
 
 After application of a low count filter described in chapter 2 (1,280 genes 
removed, and 5,845 remaining), differential expression analyses were carried 
out. Adjusted P value < 0.05, and linear fold change ≥ 2, as determined by 
DEseq2, were selected as cut-off parameters to determine which messages 





and 478 downregulated messages in the cbf5-D95A cells. A table listing all 
messages and their differential expression can be found in Dataset 
E1_de_20180606.xlsx in the online repository.   
 A gene ontology (GO) enrichment analysis of differentially expressed 
(DE) genes in cbf5-D95A compared to isogenic wild-type cells was performed 
with gProfile:R. Summary tables containing the top 20 GO categories 
[biological processes (BP) and molecular functions (MF) only] enriched in cbf5-
D95A vs. WT contrast, ranked by adjusted P value, are shown (Table 2 and 
3). Tables listing all of the BP, MF, cellular components (CC), and KEGG 
pathways found to be enriched are available in Datasets 
E1_gprofiler_up_20180606.xlsx and E1_gprofiler_down_20180606.xlsx in the 
online repository. GO enrichment analyses revealed upregulation of 1) 
nucleotide metabolism (GO:0072524, GO:0046496, and GO:0019362), 2) 
oxidation-reduction [GO:0006733, GO:0055114, GO:0016491, GO:0006979 
(response to oxidative stress, 12 of 122 are DE, adjusted P value = 1.63E-04), 
and GO:0034599 (cellular response to oxidative stress, 10 of 113 are DE, 
adjusted P value = 5.07E-03)], and 3) protein refolding (GO:0042026, 
GO:0051082 [unfolded protein binding, 9 of 83 are DE, adjusted P value = 
7.03E-04), GO:0006457 (protein folding, 11 of 110 are DE, adjusted P value = 
2.12E-02)] in the cbf5-D95A cells. Of note, (although not visible in Table 2), 
trehalose metabolism (GO:0070413, and GO:0005991) was also upregulated 





Table 2. Top 20 gene ontology (GO) categories (biological processes, BP 
and metabolic function, MF) upregulated in cbf5-D95A vs. WT 





























1.04E-08 26 182 














































































3.51E-05 6 17 
Cutoff for DE genes: fold change ≥ 2, adjusted P value cutoff of <0.05, by 
DEseq2. Number of DE genes and total number of genes in each of the top 20 
GO terms are shown. 
 
GO enrichment analyses revealed downregulation of amino acid 
biosynthesis (most GO terms listed in Table 3), and endoplasmic reticulum 
(ER) to Golgi vesicle-mediated transport (GO:0006888) in cbf5-D95A cells.  
Table 3. Top 20 GO categories (BP and MF) downregulated in cbf5-D95A 
vs. WT 
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7.49E-06 28 125 
GO:0000096 
sulfur amino acid 
metabolic process 
(BP) 







































4.21E-04 13 39 
GO:0006520 
cellular amino acid 
metabolic process 
(BP) 
5.10E-04 39 253 
GO:0006888 
ER to Golgi vesicle-
mediated transport 
(BP) 
5.14E-04 20 95 
GO:0000097 
sulfur amino acid 
biosynthetic process 
(BP) 
5.89E-04 13 40 
GO:0009070 
serine family amino 
acid biosynthetic 
process (BP) 















7.63E-03 8 18 
GO:0009069 
serine family amino 
acid metabolic 
process (BP) 






3.62E-02 15 72 









Cutoff for DE genes: fold change ≥ 2, adjusted P value cutoff of <0.05, by 
DEseq2. Number of DE genes and total number of genes in each of the top 20 
GO terms are shown. 
 
Thirty messages predicted to contain -1 PRF signals101 were 
downregulated in the cbf5-D95A cells. Of these, only 9 of the predicted slippery 
sites were followed by computationally predicted strong pseudoknots. We 
hypothesize that messages with functional -1 PRF signals would be more 
normally targeted for NMD in wild-type cells, and thus further destabilized in 
the cbf5-D95A mutation (recall increased rates of -1 PRF and increased 
recognition of stop codons in cbf5-D95A cells154), and would be below 
detectable threshold.  
UPF1, which encodes one of the key components of the NMD 
pathway159, was deleted in the isogenic cbf5-D95A and WT strains in an effort 
to identify more messages with predicted -1 PRF signals that may be functional. 
It was anticipated that this would raise the abundance of the messages targeted 
for degradation through the NMD pathway increasing their levels above the 
threshold of detection. (The resulting strains, CBF5 upf1Δ and cbf5-D95A 
upf1Δ, will also be called upf1Δ and double mutant, respectively). A second 
RNA-Seq experiment was set up with two batches each with 2 biological 
replicates of the four strains: WT, cbf5-D95A, upf1Δ, and cbf5-D95A upf1Δ. 
RNA was isolated and libraries were prepared, sequenced and analyzed as 
described above. The total number of reads generated from all libraries is listed 





Mapped sequencing data derived from all libraries (first and second 
experiment) were analyzed using a variety of methods, including PCA and 
hierarchical clustering to inspect the relationships between samples and to 
identify potential outliers. The resulting PCA plot and heat maps (Figure 23) 
showed that samples cluster by batch, and that there is a nested effect visible 
within Experiment 2, Batch 1 (E2B1). Different patterns in gene expression 
were also visible in batch E2B1 when examining all samples in Integrative 
Genomics Viewer (IGV, representative images are shown in Appendix 5, 
Figures 36 and 37). Different surrogate variable analyses did not correct this, 
and batch E2B1 was considered an outlier and excluded from further analyses. 
The removed batch contained samples hpgl0774 through hpgl0781, resulting 
in a total of 6 samples of CBF5 UPF1 (hpgl0564 through hpgl0567, hpgl0782, 
and hpgl0786), 6 samples of cbf5-D95A UPF1 (hpgl0568 through hpgl0571, 
hpgl0783, and hpgl0787), 2 samples of CBF5 upf1Δ (hpgl0784, and hpgl0788), 
and 2 samples of cbf5-D95A upf1Δ (hpgl0785, and hpgl0789) for analyses. 
Following normalization and surrogate variable analysis, the hierarchical 
clustering (Figure 24A) and PCA plot of the remaining samples (Figure 24B) 






Figure 23. Quality control metrics suggesting the removal of batch E2B1 
Hierarchical clustering analyses using (A) Pearson correlation and (B) 
Euclidean distances along with a (C) standard medium Pearson correlation 
between each sample and (D) Principal Component Analyses of the log2, cpm, 
quantile, and low-count filtered data (6,095 of 7,125 genes remained after 








Figure 24. Global statistical assessment of biological replicates 
(A) Heat-map and (B) PCA plots of RNA-Seq data generated from the libraries 
mapped to the S. cerevisiae genome following removal of rRNA/tRNA features. 
Once the outlier batch was removed and data passed through normalization 
and surrogate variable analysis, the clustering by condition became evident in 
both analyses. In both plots, each sample is color coded by condition. 
 
The numbers of genes that emerged as differentially expressed (DE) 
with adjusted P value < 0.05, in pairwise contrasts of each genotype are shown 
in Figure 25 (see Dataset E1E2_de_20180212.xlsx in online repository for the 
complete list). Full sets of enriched GO categories generated from analysis of 
DE genes in each pairwise contrast are available in Datasets 
E1E2_gprofiler_up_20180212.xlsx and E1E2_gprofiler_down_20180212.xlsx 
in the online repository. A summary table with the top 20 GO categories in cbf5-
D95A vs. WT is below (Table 4), and revealed increased nucleotide 
metabolism (GO:0072524, GO:0019362, and GO:0046496),and response to 
oxidative stress (GO:0055114, GO:0006733, GO:0016491, GO:0016614), 





acid phosphatase activity (GO:0003993), was found to be downregulated in 
cbf5-D95A cells when all the RNA-Seq data was combined.  
 
Figure 25. Differentially expressed genes with adjusted P value <0.05 in 
all pairwise contrasts 
Red represents downregulated massages, and green represents upregulated 
messages. The lightest color represents genes for which the linear fold change 
≤ 2, middle color is for messages that have 2 < linear fold change ≤ 4, and the 









Table 4. Top 20 GO categories (BP and MF) enriched for cbf5-D95A vs. 
WT for combined data 



































1.24E-08 18 82 



























2.90E-06 30 338 
GO:0019172 
glyoxalase III activity 
(MF) 





































1.17E-04 5 6 
GO:0016614 
oxidoreductase 
activity, acting on 
CH-OH group of 
donors (MF) 
1.47E-04 13 83 




4.64E-02 4 9 
Cutoff for DE genes: fold change ≥ 2, adjusted P value cutoff of <0.05, by 
DEseq2. Number of DE genes and total number of genes in each of the top 20 
GO terms are shown. 
 
Summary tables of GO enrichment analyses for the other contrasts are 
listed in Appendix 5 (Tables 14-17). The upf1Δ vs. WT contrast revealed 
upregulation of 1) cell cycle, 2) cell fate, 3) cellular transport and transport 
mechanisms, 4) control of cellular organization, and 5) energy generation 
(Table 14 in Appendix 5). Downregulated GO categories for this contrast fall 
under the broad category of protein translation (Table 14 in Appendix 5).  
Analysis of cbf5-D95A upf1Δ vs. cbf5-D95A revealed upregulation of cell 
cycle and cellular transport categories, and downregulation of protein synthesis 
(Table 15 in Appendix 5). Analysis of cbf5-D95A upf1Δ vs. upf1Δ revealed 





downregulation of cell cycle and control of cellular organization (Table 16 in 
Appendix 5).  
Analysis of cbf5-D95A upf1Δ vs. WT revealed upregulation of cellular 
transport and control of cellular organization, and downregulation of protein 
synthesis and transcription (Table 17 in Appendix 5).  
In the dataset containing E1 and E2B2, there were only 3 predicted -1 
PRF signal containing messages (CIT2, ADY3, and YOR365C) that were 
downregulated in the cbf5-D95A vs. WT cells. Of these only CIT2 has a strong 
predicted pseudoknot structure following the slippery site. None of the three 
messages were upregulated in upf1Δ vs. WT. Only YOR365C was upregulated 
in the double mutant vs. cbf5-D95A. However, YOR365C is described as a 
putative protein of unknown function in SGD. For these reasons, the 
identification and validation of functional -1 PRF signals was not pursued 
further. 
 
cbf5-D95A cells have lower levels of ROS in post-diauxic phase 
The RNA-Seq data indicated that the expression of genes involved in 
cellular response to oxidative stress is upregulated in cbf5-D95A vs. WT cells 
(Table 2 and 4).  Hydrogen peroxide  (H2O2) exists in equilibrium inside and 
outside of the cell143,144,160, and thus the amount of H2O2 outside of the cell can 
be measured as a proxy for the amount inside the cells143,144,160. H2O2 levels 
outside the cells were measured using an Amplex® Red Hydrogen 





outside of the cell to produce a fluorescent compound, resorufin, in the 
presence of horseradish peroxidase161–164. Using this kit, a trial experiment was 
carried out using WT cells at mid-log growth and a standard curve (varying 
concentrations of 0 to 5 µM H2O2). It was determined that the background (502 
AU) was much lower than the other reads (highest fluorescence = 26,442 AU 
for 5 µM H2O2). However, it did not appear that the WT cells were secreting 
H2O2 at this growth phase, as the reads were very close to background (data 
not shown). 
In order to obtain higher reads and compare the levels of H2O2 being 
secreted by WT and cbf5-D95A cells, the Amplex® Red kit was used when the 
cells reached the post-diauxic stage143. Cells were grown in the Synergy HT 
under the same conditions used for the growth curve experiments. Wild-type 
cells were collected at 22 hours, and cbf5-D95A cells at 42 hours. Different 
numbers of cells (2 x 107, 4 x 107, and 8 x 107) were resuspended in 1X reaction 
buffer and allowed to grow for 1 hour for the H2O2 levels to equilibrate. After 
loading the samples with Amplex® Red, cells were incubated in the dark for 30 
minutes. Fluorescence was measured on a Promega GloMax Multi + Detection 
System using the green filter (absorbance: 525 nm and emission: 580-640 nm). 
Standard curves with varying concentrations of H2O2 (between 0 to 5 µM H2O2) 
were determined for each experiment. H2O2 concentrations were calculated 
using the standard curve from the same experiment. No statistically 
significance difference in concentration of H2O2 was found between the two 





concentration of H2O2 in cbf5-D95A cells was about half of that in the WT cells 
(Figure 26).  
 
Figure 26. cbf5-D95A cells have lower reactive oxygen species levels at 
stationary phase 
Samples were grown in 500 µl of YPAD media in 12-well plates in a Synergy 
HT plate reader. Chamber was kept at 30°C. Plate was stationary, with 1 
minute of shaking prior to each OD595 measurement taken every hour. Wild-
type cells were collected at 22 hours, and cbf5-D95A cells at 42 hours. Cells (2 
x 107, 4 x 107, and 8 x 107) were resuspended in 1X reaction buffer, and allowed 
to grow for 1 hour shaking at 30°C. Samples were loaded with Amplex® Red 
and incubated for 30 minutes in the dark. Samples were assayed on a Promega 
GloMax Multi + Detection System using the blue filter (absorbance: 490 nm and 
emission: 510-570 nm). N = 4 biological replicates in independent experiments. 
Each dot represents a biological replicate. Mean and standard deviation are 
also shown. Statistical significance was calculated using a non-parametric one-
way ANOVA. **, p < 0.01. 
 
cbf5-D95A cells are pre-adapted to ER stress 
Consistent with the finding of increased upregulation of genes involved 
in protein refolding (Table 2), and the downregulation of ER to Golgi transport 
(Table 3), defects in translational fidelity were predicted to increase the 
synthesis of defective proteins, and that accumulation of misfolded proteins in 
the ER should constitutively induce the unfolded protein response (UPR). High 





adapted) to other ER stressors. Tunicamycin, which prevents N-linked 
glycosylation of proteins in the ER, leads to the enhanced accumulation of 
misfolded proteins in the ER165,166. This leads to activation of IRE1 protein, 
which splices HAC1 mRNA. The spliced HAC1 message encodes a 
transcription factor that binds the unfolded protein response elements in the 
promoters of genes involved in UPR response. The sensitivity of cells to ER 
stress was assayed using tunicamycin in two different ways: 1) effects on yeast 
growth, and 2) effects on HAC1 mRNA splicing.  
Yeast were grown in YPAD, back diluted and serial dilutions spotted on 
YPAD plates with or without 1 µg/ml tunicamycin. While the cbf5-D95A strain 
grew more slowly in YPAD media, these grew faster than the WT in media 
containing tunicamycin as compared to isogenic WT controls (Figure 27). 
 
Figure 27. cbf5-D95A cells are less sensitive to ER stress than WT cells 
Yeast was grown in YPAD liquid media, then backdiluted and spotted on YPAD 
plates with or without 1µg/ml tunicamycin. Three biological replicates were 
plated. Representative images shown. 
 
The UPR is characterized by activation of Ire1p in yeast, through 
autophosphorylation in response to unfolded proteins167–170. The primary HAC1 
transcript contains a 252 nucleotide intron (HAC1U), which is spliced by Ire1p 





encodes a transcription factor which binds to the unfolded protein response 
element (UPRE) in the promoter of genes required for UPR response171. 
Although the HAC1 mRNA is always expressed in cells, Hac1p is only detected 
in UPR-activated cells; this could be due to 1) message not being translated, 
or 2) protein being degraded rapidly171.The UPR response is similar in human 
cells, where the HAC1 ortholog is XBP1172,173.  
To determine the effects of tunicamycin on HAC1 mRNA splicing, cells 
were treated with 1µg/ml tunicamycin for 1 hour, and RNA was extracted from 
1 x 107 cells. cDNA was synthesized from 450 ng of RNA, and the HAC1 intron 
region was amplified. The basal level of expression of HAC1 mRNA was 
determined to be higher in the cbf5-D95A cells than in WT cells. Most of the 
HAC1 mRNA in WT cells treated with tunicamycin was spliced, while only about 

















Figure 28. HAC1 mRNA splicing in cbf5-D95A cells as a result of ER stress 
Yeast was grown in YPAD, back diluted and treated with 1µg/ml tunicamycin 
for 1 hour. RNA was isolated from 1 x 107 cells, and cDNA synthesized from 
450 ng of RNA. Two µl of a 1:10 cDNA dilution were used as template for PCR 
reactions using primers to amplify the HAC1 intron region. PCR products were 
separated on a 1.5% agarose gel. A 111 bp product corresponds to spliced 
HAC1 mRNA (HAC1S), and 363 bp product corresponds to unspliced HAC1 
mRNA (HAC1U). Five hundred ng of RNA were separated on a 1.5% agarose 
gel. Three biological replicates were treated and processed through the full 
protocol. 
 
Yeast models of haploinsufficiency display varying sensitivities to ER stress 
To determine if a similar pre-adaptation was present in pseudo-
haploinsufficient yeast strains, the effects of tunicamycin on cell growth were 
determined in these cells. Control experiments were carried out with the 
isogenic ohnolog duplication strains.  
Yeast cells were grown in liquid YPAD media, and after back dilution, 
serial dilutions were plated on YPAD plates with or without 1 µg/ml tunicamycin. 
rps0bΔ and rps19bΔ cells, which were slower-growing than WT cells on YPAD 
plates, grew faster than the WT strain in the presence of tunicamycin (Figure 
29A, top and bottom panels). rps14aΔ cells, whose growth was similar to WT 





tunicamycin (Figure 29A, middle panel). rps19aΔ cells, whose growth was 
similar to WT on YPAD plates, grew slower than the WT strain in the presence 
of tunicamycin (Figure 29A, bottom panel). These data indicate that rps0bΔ, 
rps14aΔ, and rps19bΔ cells displayed decreased sensitivity to a second 
stressor. On the other hand, rps19aΔ cells displayed increased sensitivity to 
ER stressor. The experiment was repeated with the ohnolog duplication strains, 
as all changes in sensitivity to ER stress were rescued, and all strains grew at 
the same rate as the WT cells on the same plate (Figure 29B). 
 
 
Figure 29.  Sensitivity of yeast models of haploinsufficiency to ER stress 
Dilution spot assays of yeast ohnolog deletion and duplication strains in YPAD 
plates with or without 1 µg/ml tunicamycin. Three biological replicates were 
plated. Representative images shown.  
 
Discussion 
Prior studies showed changes in translational fidelity in X-DC patients 





profiles of DBA patient-derived cells (Figure 19 and 20) and yeast models of 
haploinsufficiency (Figures 12-18) were monitored to test the hypothesis that 
ribosomopathies are generally associated with translational fidelity defects. 
Interestingly, while gene-specific differences changes in translational fidelity 
were observed in many of the pseudo-haploinsufficient yeast strains, these 
were all rescued in the control ohnolog duplication strains (Figures 12, 15, and 
16). These observations are consistent with a gene dosage, rather than a 
specialized ribosome model.  
Quantitative analysis of the yeast X-DC model growth suggested that 
cbf5-D95A cells may be pre-adapted to stress (Figure 21). GO analyses of 
RNA-seq data revealed that cbf5-D95A cells have upregulated nucleotide 
biosynthesis, response to oxidative stress, protein refolding, and trehalose 
metabolism (Tables 2 and 4). The same cells displayed downregulated amino 
acid biosynthesis and ER to Golgi vesicle-mediated transport than WT cells 
(Table 3). We hypothesize that these changes may be due to the intrinsic 
instability of mutant ribosomes. Ribosome biosynthesis accounts for ~80% of 
the metabolic load in actively growing yeast cells174. Enhanced ribosome 
turnover would further increase the demands on cellular metabolism. This 
would necessitate increased energy consumption to produce the increased 
amounts of ATP and GTP required for ribosome biosynthesis, hydrolysis of 
which would result in increased reactive oxygen species (ROS), resulting in 
upregulation of response to oxidative stress. Increased rates of ribosome 





meet the demands for the synthesis of new rRNAs.  In addition, decreased 
translational fidelity is predicted to increase the fraction of misfolded proteins, 
as reflected in the upregulation of protein refolding machinery, and trehalose is 
associated with upregulated stress response175.  In contrast, the unfolded 
protein response is localized in the endoplasmic reticulum: increased levels of 
misfolded proteins is predicted to increase the flux of these proteins to the 
proteasome, and away from the Golgi. Furthermore, increased rates of 
proteosomal amino acid scavenging would be expected to provide negative 
feedback on the amino acid biosynthetic machinery. A future experiment will 
directly address the hypothesis that mutant ribosomes are unstable by 
measuring ribosome half-lives in isogenic wild-type and cbf5-D95A cells. 
Follow-up studies determined that cbf5-D95A stationary phase cells 
have lower ROS levels than WT cells (Figure 26). This observation is 
consistent with the longer plateau of the cbf5-D95A cells upon reaching 
stationary phase (Figure 21).  These results support the hypothesis that cells 
carrying this mutation may be pre-adapted to stress143. 
Assays monitoring a second type of stress, ER stress induced by 
tunicamycin, revealed that cbf5-D95A cells were less sensitive than WT cells, 
as shown by growth in plates containing tunicamycin (Figure 27). It was 
determined that cbf5-D95A cells have increased basal expression of HAC1 
mRNA, and that after tunicamycin treatment these cells display approximately 
the same amount of spliced HAC1 mRNA as the WT cells, also supporting the 





Ohnolog-deletion specific effects were observed with regard to ER 
stress sensitivity monitored by growth in the presence of tunicamycin in the 
pseudo-haploinsufficient yeast models. This experiment was repeated with the 
control ohnolog duplication strains, and differences observed in ohnolog 
deletion strains were rescued (Figure 29). This supports the gene dosage 
model to explain ribosomopathies.  
Taken as a whole, the data presented here points to the metabolic 
imbalance model149 (and not specialized ribosomes146) as the explanation for 
the translational fidelity defects and differences in sensitivity to ER stress 
observed in the pseudo-haploinsufficient yeast strains. The caveats are that 
this can only be extended to yeast growing in rich media, and further studies 
are required to determine if this finding holds true in human cells. It appears 
that there is a pre-adaptation of cbf5-D95A cells to handle other stresses better 
as a result of the mutation they carry. A longer plateau upon reaching stationary 
phase in growth curve analysis, lower ROS levels, and decreased sensitivity to 







Chapter 4: The clinical presentation of MacInnes 
Syndrome, a novel ribosomopathy due to mutations in 




A novel ribosomopathy involving uS12 was recently identified by our 
collaborator, Dr. Alyson MacInnes, at the euroDBA in the Netherlands. Two 
unrelated patients were identified with mutations in the RPS23 gene, encoding 
uS12-R67K and uS12-F120I68. The patients symptoms include dysmorphic 
features such as short stature, microcephaly, flat back of the skull, simian 
palmar creases, epicanthic eye folds, long eyelashes, fetal finger pads, and 
hearing loss68. The patient carrying the uS12-R67K mutation was additionally 
diagnosed with intellectual disability and autism spectrum disorder68. While 
some of these symptoms are similar to those presented by X-DC and DBA 
patients, these two patients did not present with anemia or any other 
hematologic symptoms68. OMIM named this syndrome Brachycephaly, 
trichomegaly, and developmental delay (BTDD, OMIM #617412) or MacInnes 
Syndrome (MCINS)176, after the publication of this project. 
Ribosomal protein uS12 (encoded by RPS23 gene) is part of the small 
ribosomal subunit and lies within the decoding center68,177. This protein is in 





the ribosome discriminate among aminoacyl-tRNAs177–180. Residue R67 lies in 
the PNSA loop, and F120I lies in the PGVRY loop, both highly conserved68,181–
183. Arginine 67 forms two polar contacts with guanosine 67 in 18S rRNA, which 
are predicted by PyMOL to be disrupted in the R67K mutant68. Phenylalanine 
120, on the other hand, is predicted to interact with phenylalanine 41 in uS12 
by pi-pi stacking, which would not be possible with the F120I mutation68. 
In humans, uS12 is post-translationally hydroxylated at proline-62 by 
OGFOD1, 2-oxoglutarate and iron dependent oxygenase domain containing 
protein 1184. This residue is located in a loop that protrudes into the decoding 
center and is conserved through yeast184,185. It was determined that >95% of 
uS12 proteins in the ribosomes are hydroxylated184. In yeast, there are 2 gene 
ohnologs (RS23A and RS23B), which encode the same protein, uS1249. 
Proline-64 is post-translationally dihydroxylated in yeast uS12185. In this case, 
hydroxylation reactions are catalyzed by Tpa1p, the yeast ortholog of 
OGFOD1185. Strains harboring mutations at P64 are not viable and those with 
mutations in nearby residues have growth defects185. The effect of uS12 
hydroxylation on stop codon readthrough depends on the context/sequence, 
i.e. decreased accuracy for UAA stop codon and increased accuracy for UGA 
stop codon for cells in which TPA1 had been deleted185. uS12-K62R cells 
displayed increased UAA stop codon readthrough185. In a separate study, the 
uS12-K62R cells were found to have increased paromomycin sensitivity and 
increased nonsense suppression, which the authors suggest may be due to 





third study also found that yeast cells carrying uS12-K62R displayed increased 
translation error frequency, which they calculated by taking the ratio of 
incorporated [3H] leucine to the sum of incorporated [3H] leucine and [3H] 
phenylalanine in an in vitro translation of poly (U) mRNA templates183. 
As part of an international collaboration to study the effects of the uS12 
mutations associated with the newly identified MacInnes Syndrome, our 
contribution consisted of determining the effects of the uS12-R67K and uS12-
F120I mutations on translational fidelity. To answer this question, both yeast 
model and patient-derived fibroblasts were used. 
The laboratory of Dr. Susan Baserga, at Yale University, kindly provided 
us with a yeast model strain (rps23a-R69K), an isogenic WT, and an rps23a-
K62R strain as a control. To develop this set of strains, the endogenous 
RPS23B gene was deleted and the endogenous RS23A was placed under the 
control of a galactose-inducible promoter. The resulting yeast strain was 
transformed with plasmids containing different versions of RPS23A: wild-type, 
K62R (control mutation which, as described above, leads to translational fidelity 
defects182,183,185), and R69K (model of patient mutation). By first growing the 
cells in galactose/raffinose medium, where both the endogenous and plasmid-
borne copies of RPS23A are expressed, a large amount of cells can be 
obtained. Then, 24 hours prior to the experiment, replacement with dextrose 
medium allows depletion of the endogenous uS12, so that the assays reflect 





both patients (RPS23-R67K and RPS23-F120I) and two healthy controls (C109 
and 9E0872) were kindly provided by Dr. MacInnes. 
 
Results 
The yeast model of MacInnes Syndrome displays translational fidelity defects 
Given that ribosomopathies are due to mutations that affect ribosome 
biogenesis, it is logical to assay the ribosome’s translational accuracy. To 
determine the translational fidelity profile of the yeast model of MacInnes 
Syndrome, assays were carried out with yeast transformed with dual luciferase 
reporters specifically designed to measure rates of -1 PRF, +1 PRF, stop codon 
readthrough, and missense suppression. In addition to the rps23a-R69K 
mutant that mimics one of the patient’s mutations, the rps23a-K62R mutant 
was also used as a control, since it had been previously shown to have 
translational fidelity defects182,183,185.  
Both rps23a-K62R and rps23a-R69K cells were shown to have higher 
rates of -1 PRF promoted by the STN1 frameshift signal than the WT cells 
(Figure 30A). On the other hand, rps23a-K62R cells had lower rates of -1 PRF 
promoted by the L-A frameshift signal than the WT cells (Figure 30A). The rate 
of UAA stop codon readthrough was increased in rps23a-K62R cells, as 
observed previously185 (Figure 30B). rps23a-R69K cells displayed higher rates 
of UAA and UAG stop codon readthrough than WT cells (Figure 30B). 
Missense suppression was assayed with reporters in which arginine 218 in the 





(AGA  AGC) or non-cognate (AGA  TCT) mutation, rendering it catalytically 
inactive138. rps23a-K62R cells displayed higher rates of both non-cognate, and 
near-cognate missense suppression than WT cells, as observed previously183 
(Figure 30C). rps23a-R69K cells had higher rates of non-cognate missense 
suppression than the WT cells, while rates of near-cognate missense 
suppression remained unchanged (Figure 30C). The rate of +1 PRF was 
higher than WT in rps23a-K62R, while it remained unchanged in rps23a-R69K 
(Figure 30D). 
 
Figure 30. Translational fidelity defects in the yeast model of MacInnes 
Syndrome. 
Rates of (A) -1 PRF, (B) stop codon readthrough, (C) missense suppression, 
and (D) +1 PRF in the yeast model of MacInnes Syndrome (rps23a-R69K) and 
the control strain (rps23a-K62R) were determined by dual luciferase assays. A 
minimum of seven biological replicates were assayed in triplicate. Student’s t-
test was used to determine statistically significant differences122: * p<0.05, and 






Patient-derived fibroblasts display increased rates of UAA stop codon 
readthrough 
Translational fidelity was also assayed in fibroblasts derived from both 
MacInnes Syndrome patients (uS12-R67K and uS12-F120I) and two healthy 
controls (C109 and 9E0872), which were kindly provided by Dr. MacInnes. 
Fibroblasts were transfected with dual luciferase reporters by electroporation. 
Rates of UAA stop codon readthrough were higher in both uS12-R67K and 
uS12-F120I patient fibroblasts than in healthy control fibroblasts (Figure 31). 
These results are congruent with the increased UAA stop codon readthrough 










Figure 31. UAA stop codon readthrough in fibroblasts derived from the 
two MacInnes Syndrome patients 
Rates of UAA stop codon readthrough were assayed by dual luciferase assays 
in fibroblasts derived from the two MacInnes Syndrome patients, and two 
healthy controls. A minimum of three biological replicates were assayed in 
triplicate. Student’s t-test was used to determine statistical significance122: * 
p<0.05, and ** p<0.01. Figure first published in Paolini et al., 201768. 
 
 
The yeast model of MacInnes Syndrome displays lower sensitivity to ER stress 
than WT cells 
The sensitivity of cells to ER stress was assayed in two different ways. 
To determine the effects of tunicamycin, an ER stressor, on yeast growth, 
rps23a-K62R and rps23a-R69K cells were cultured alongside the WT cells in –
trp media containing galactose and raffinose. Twenty-four hours before the 
cultures were back diluted, and spotted in YPAD and YPAD with 1 µg/ml 





to ensure no endogenous uS12 was present, as described above. Samples 
were incubated at 30°C and photographed daily. The WT cells grew faster than 
both rps23a-K62R and rps23a-R69K mutants in the media without tunicamycin 
(Figure 32, middle left). The two mutants had similar growth rates (Figure 32, 
top and bottom left). On the plates treated with tunicamycin, rps23a-R69K cells 
grew faster than the WT cells, indicating decreased sensitivity to tunicamycin 
and ER stress (Figure 32, middle and bottom right). Rps23a-K62R cells were 
severely sensitive to tunicamycin and barely grew on the first dilution spot 
(Figure 32, top right). 
 
Figure 32. rps23a-R69K cells displayed decreased sensitivity to ER stress 
Yeast was grown in –trp media containing galactose and raffinose. Twenty-four 
hours before the experiment, media was switched to –trp media containing 
dextrose, to ensure expression of the mutant rps23a. Yeast was backdiluted, 
and serial dilutions were spotted on –trp media containing dextrose with or 
without 1µg/ml tunicamycin. Three biological replicates were assayed.  
 
 
As described earlier, the unfolded protein response is activated through 
activation of IRE1, which splices HAC1 mRNA in the presence of ER 
stress167,168,171. rps23a-K62R and rps23a-R69K cells were cultured in –trp 
media with galactose and raffinose, and media was changed to –trp with 





with 1 µg/ml tunicamycin for 1 hour. RNA was isolated from 1 x 107 cells, and 
cDNA synthesized from 450 ng of RNA (due to limitation in reaction volume). 
HAC1 mRNA splicing status was determined by PCR with primers designed to 
amplify the HAC1 intron region. As a loading control, 500 ng of RNA were 
loaded on an agarose gel for separation of rRNA. In untreated samples, 
RPS23A-R69K had the highest basal levels of unspliced HAC1 mRNA (Figure 
33, lane 3). After tunicamycin treatment, the WT and rps23a-R69K cells had a 
low level of spliced HAC1 mRNA, while about 50% of HAC1 mRNA in rps23a-
K62R cells was spliced (Figure 33, lanes 4-6). 
 
Figure 33. HAC1 mRNA splicing in rps23a mutant cells as a result of ER 
stress 
Yeast was grown in –trp media containing galactose and raffinose. Twenty-four 
hours before the experiment, media was switched to –trp media containing 
dextrose, to ensure expression of the mutant rps23a. Cells were treated with 
1µg/ml tunicamycin for 1 hour, and RNA was isolated from 1 x 107 cells. cDNA 
was synthesized from 450 ng of RNA, and the HAC1 intron region was 
amplified by PCR. Twenty-five µl of the PCR products were separated on a 
1.5% agarose gel. A 111 bp product is expected for spliced HAC1, and 363 bp 
product is expected for unspliced HAC1. Five hundred ng of RNA were 
separated on a native 1.5% agarose gel. Three biological replicates were 






As part of this project, it was determined that the patient cells have 
ribosome biogenesis defects. There is an accumulation of 18S-E pre-rRNA in 
cells carrying the uS12-R67K mutation, suggesting that one of the final steps 
in maturation of pre-rRNA is disrupted, as is the case with DBA patients with 
mutations in RPS10, RPS26, RPL5, or RPL11 (encoding ribosomal proteins 
eS10, eS26, uL18, and uL5, respectively)27,30,49,68. Polysome profiles showed 
a decrease in the 40S subunit peak in uS12-R67K fibroblasts and LCL, which 
could not be counteracted by the increase of uS12 mRNA transcription 
observed in the mutant fibroblasts68. The decrease in 40S subunit peak is 
similar to what was seen in DBA patient cells with mutations RPS19 (encoding 
ribosomal protein eS19)49,71,72. Interestingly, examination of polysome fractions 
showed that only 10% of translating ribosomes carry the R67K mutation68, 
suggesting there may be a mechanism to exclude mutant uS12 similar to what 
was observed in E. coli186. 
Since the R67K mutation occurs in close proximity to the P-62 residue 
that is hydroxylated in uS12, hydroxylation state of these mutant proteins was 
determined. While hydroxylation of P-62 by OGFOD1 is reduced in uS12-R67K 
LCL, there is no change in the interaction between uS12 and OGFOD168. On 
the other hand, interaction between uS12-F120I and OGFOD1 is disturbed, in 
addition to the reduction in hydroxylation of P-6268. 
When cells are exposed to environmental stress, cytoplasmic stress 





of mRNAs not required for stress response187,188. Deregulated stress granule 
formation has been associated with pathologies such as neuronal dysfunction 
and degeneration189. Patient fibroblasts were exposed to arsenite to induce 
oxidative stress and induce formation of stress granules as a result. The cells 
carrying the R67K and F120I mutations in uS12 developed more stress 
granules than the healthy controls, suggesting that patient cells are more 
sensitive to oxidative stress68. It is known that pre-initiation complexes requiring 
repair are recruited to stress granules in the presence of arsenite190, which 
could explain the increase in stress granules in the patient cells. 
 It has been shown that increased oxidative stress levels or reduced 
levels of OGFOD1 can lead to changes in the fidelity of protein translation184,191. 
Changes in translational recoding were confirmed, as described in our 
contribution to this project. The yeast model of MacInnes syndrome displayed 
an increase in -1 PRF stimulated by the STN1 frameshift signal, and in non-
cognate missense suppression. These yeast rps23a-R67K cells also showed 
an increase in UAA and UAG stop codon readthrough. Fibroblasts derived from 
both patients also displayed increase UAA stop codon readthrough when 
compared to two healthy controls. It is worth noting that +1 PRF is caused by 
slipping of the peptidyl-tRNA, while -1 PRF is driven by slippage of both the 
peptidyl- and aminoacyl-tRNAs99,107. Missense and nonsense suppression rely 
only on the A-site of the ribosome. These details taken together with the 
translational fidelity data suggest that the uS12 mutants are most likely 





This study uncovered two patients with similar phenotypic presentation 
carrying two different mutations in conserved regions of uS12, the PNSA and 
PGVRY domains. The uS12-R67K mutation was shown to affect a later step in 
pre-rRNA maturation, and both mutations impair OGFOD1 hydroxylation of 
residue P-62 in uS12 and increase sensitivity of the cells to oxidative stress. 
This, in turn leads to the variations in translational fidelity observed in the 
fibroblasts derived from the two patients and in the yeast model of MacInnes 
Syndrome. The low percentage of mutant uS12 found in the polysome fractions 
of the polysome profile obtained from uS12-R67K LCL suggests that there may 
be a mechanism to prevent ribosomes carrying the mutated uS12 from entering 













Chapter 5:  Conclusions and future directions 
 
The ribosome is central to the process of translating mRNAs to proteins: 
it is critical that it maintains proper reading frame and correct decoding of 
codons. Ribosomopathies are diseases in which mutations of ribosomal 
proteins, or of ribosome biogenesis factors, lead to defects in ribosome 
biogenesis. While it has been shown that cells in ribosomopathy patients and 
models have ribosome biogenesis defects, the ribosome function in the patient 
cells has not been extensively studied. Here, we monitored translational fidelity 
in yeast models of ribosomopathies, as well as cells derived from MacInnes 
Syndrome patients and from DBA patients carrying two novel mutations in 
RPL9 (uL6). An RNA-seq experiment was carried out with the yeast X-DC 
model, and led us to further explore the consequences of ribosomopathological 
mutations on oxidative and ER stress.  
As was described in chapter 1, most ribosomopathy patients present 
with anemia, and a unique set of symptoms dependent on which specific 
disorder they have. Two major models have been proposed to explain how the 
mutations cause the disease. First, specialized ribosomes have been proposed 
as a solution146,147. Supporters of this model list the unique sets of symptoms 
as an indication of this20,29. They suggest that ribosomal proteins, as part of the 
ribosome, have unique functions in different tissues, with Rpl38 and regulation 
of Hox mRNA translation given as an example 148,192–195. An alternative model 
suggests that ribosomopathies are due to metabolic imbalance149–151. 





lower concentration of ribosomes in the cells, which can affect translation of 
messages depending on rates of translation initiation149,152. Supporting 
evidence includes translation of GATA1, which is mutated in some DBA 
patients43,148,153.  
We determined the translational fidelity profile of pseudo-
haploinsufficient yeast models of three ribosomopathies. While different assays 
of translational fidelity revealed ohnolog-specific effects, ribosomal protein 
ohnolog duplication corrected the defects seen in the model yeast strains 
(Figures 12, 15, 16). These data suggest gene dosage and support the 
metabolic imbalance model. Consistent with this, yeast ribosomal protein 
ohnologs have been shown to be expressed at different levels, which may 
explain our initial observations196–199. We hasten to add however, that the 
observations and conclusions made here are limited to  laboratory yeast 
growing in glucose and nitrogen source rich medium, and thus merely 
represent a starting point down the path to more detailed investigations. 
Ribosome specialization may be operative in yeast under different nutrient 
conditions, during sporulation (a model of differentiation), or in wild-source 
diploid yeast strains. Furthermore, additional research is required to address 
this question in higher eukaryotes, where cell type and development of the 
organism may require the proposed “specialized” ribosomes. 
It has been shown that translational fidelity defects can protect bacterial 
cells against oxidative stress200. Fan et al. used bacterial strains carrying 





readthrough200. Protein synthesis rate was not affected in either mutant. An 
RNA-seq experiment revealed upregulation of antioxidant genes [including 
katE (catalase that scavenges H2O2) and osmC (reduces hydroperoxide)] in 
rpsD*, and downregulation of these same genes in rpsL*.  Upon treatment of 
the cells with 5 mM H2O2, which kills the WT cells, rpsD* cells had increased 
survival rate, while rpsL* cells were more sensitive. Deletion of KatE and OsmC 
in the rpsD* cells increased sensitivity of the cells to treatment with H2O2. katE 
and osmC are regulated by rpoS, a factor controlling general stress response. 
Deleting rpoS in either the WT or rpsD* cells led to the highest sensitivity to 
H2O2. Overexpression of KatE and RpoS protected WT and rpsD* cells against 
H2O2. Western bot analysis showed that RpoS was increased in rpsD* cells 
and decreased in rpsL* cells. Canavanine, a structural analog of arginine, is 
misincorporated during protein synthesis if present in the environment. Addition 
of canavanine increased protection of WT cells to H2O2. These results suggest 
that mistranslation upregulates general stress response, which in turn is 
adaptive to oxidative stress conditions in E. coli. A similar effect was observed 
in cbf5-D95A cells, which have translational fidelity defects100,154, and reduced 
levels of reactive oxygen species (Figure 26).  
Growth curve analysis showed cbf5-D95A cells living longer than the 
WT cells upon reaching stationary phase, suggesting that they may be pre-
adapted to some stressors (Figure 21). RNA-seq analyses revealed 
upregulation of nucleotide metabolism, response to oxidative stress, protein 





cells (Table 2 and 4). We hypothesize that increased nucleotide metabolism is 
due to increased ribosome biosynthesis in cbf5-D95A cells. This is an energy 
intensive process, and production of ATP in the mitochondria creates oxidative 
free radicals. The cells then upregulate oxidative stress response genes to 
lower reactive oxygen species. We posit that decreased translational fidelity is 
leading to defective proteins, triggering the unfolded protein response. 
Trehalose is synthesized by yeast as a response to stress, and has been 
shown to increase lifespan not only in yeast, but also in Caenorhabditis elegans  
and Drosophila melanogaster201–204. Our results are consistent with previous 
studies showing that zebrafish models of DBA and 5q- Syndrome (RPS19 and 
RPS14 deficiency, respectively) displayed upregulation of stress response 
205,206.  
Amino acid biosynthesis and ER to Golgi vesicle-mediated transport 
were downregulated in cbf5-D95A cells (Table 3). We hypothesize this is due 
to these cells having lower translational capacity, and as such having 
decreased need for amino acid biosynthesis. These results are consistent with 
those found in ribosomopathy patients. Amino acid biosynthesis was 
downregulated in RPS19-deficient DBA patient-derived fibroblasts and 
LCLs207,208.  
Based on the available data, we hypothesized that the cbf5-D95A cells 
contain ribosomes with translational fidelity defects and are synthesizing 
defective proteins66,100,154. These proteins are likely not processed correctly in 





This explanation fits with the downregulation of ER to Golgi transport seen in 
the cbf5-D95A cells (Table 3) and upregulation of protein folding (Table 2).  
The sensitivity of yeast ribosomopathy models to tunicamycin, an ER 
stressor, was studied. X-DC and MacInnes Syndrome models were less 
sensitive to tunicamycin and had increased basal expression of HAC1 mRNA 
(Figures 27, 28, 32, and 33). Models of ICA and 5q- Syndrome were also less 
sensitive than WT cells when growing in the presence of tunicamycin (Figure 
29A). The yeast models of DBA, i.e. rps19aΔ and rps19bΔ, had an increase 
and a decrease in tunicamycin sensitivity, respectively (Figure 29A). As 
discussed above, the difference in phenotype may be due to differences in 
ohnolog expression196–199. 
We hypothesize that the cbf5-D95A ribosomes have greater turnover 
rates, due to defective function. Ribosome biosynthesis is an energetically 
expensive process174. Increased mitochondrial function to produce sufficient 
ATP to supply to this process may be resulting in the upregulation of genes 
involved in the response to oxidative stress (Table 2 and 4). To test the 
ribosome turnover hypothesis, future work will include measuring ribosome 
half-life taking into account doubling time of the cells. If ribosome turnover is 
increased in cbf5-D95A cells, a glucose consumption assay will follow this 
experiment. We hypothesize that cells harboring the cbf5-D95A mutation will 






Appendix 1: Yeast strains 
 
Table 5. Yeast strains used in this study 
Strain Genotype/Description 
yJD1524 
ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 ura3-1 cbf5::TRP1 
+ CBF5 on pRS313 
yJD1525 
ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 ura3-1 cbf5::TRP1 
+ CBF5 D95A on pRS313 
yJD1745 
ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 ura3-1 cbf5::TRP1 
upf1::LEU2 + CBF5 on pRS313 
yJD1746 
ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 ura3-1 cbf5::TRP1 
upf1::LEU2 + CBF5 D95A on pRS313 
yJD1728 
MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-
Δ200 leu2-Δ1 transformed with p424GPD empty vector 
(strain has RPS23B deleted and RPS23A under gal-inducible 
promoter kindly provided by Dr. Susan Baserga, Yale 
University) 
yJD1729 
MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-
Δ200 leu2-Δ1 (YPH499) transformed with p424GPD RPS23A-
WT  
(strain has RPS23B deleted and RPS23A under gal-inducible 
promoter kindly provided by Dr. Susan Baserga, Yale 
University) 
yJD1730 
MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-
Δ200 leu2-Δ1 (YPH499) transformed with p424GPD RPS23A-
K62R  
(strain has RPS23B deleted and RPS23A under gal-inducible 
promoter kindly provided by Dr. Susan Baserga, Yale 
University) 
yJD1731 
MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-
Δ200 leu2-Δ1 (YPH499) transformed with p424GPD RPS23A-
R69K  
(strain has RPS23B deleted and RPS23A under gal-inducible 
promoter kindly provided by Dr. Susan Baserga, Yale 
University) 
yJD1753 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0  
(BY4741, isogenic WT for 6 strains below. Dharmacon, cat # 
YSC1048) 
yJD1754 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ygr214w::KANr  
(rps0aΔ. Dharmacon, cat #YSC6273-201936399) 
yJD1756 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ylr048w::KANr  
(rps0bΔ. Dharmacon, cat #YSC6273-201928941) 






(rps14aΔ. Dharmacon, cat #YSC6273-201937084) 
yJD1758 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 yjl191w::KANr  
(rps14bΔ. Dharmacon, cat #YSC6273-201919008, 
CloneId:1234) 
yJD1759 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 yol121c::KANr 
(rps19aΔ. Dharmacon, cat #YSC6273-201937499) 
yJD1760 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ynl302c::KANr  
(rps19bΔ. Dharmacon, cat #YSC6273-201918337, 
CloneId:1142) 
yJD1732 
Mat a ura3Δ0 lys2Δ0 leu2Δ0 his3Δ200  
(JPY10H3, isogenic WT for 6 strains below. Kindly provided by 
Sherif Abou Elela’s lab at Sherbrooke University) 
yJD1739 
Mat a ura3Δ0 lys2Δ0 leu2Δ0 his3Δ200 rps0a::RPS0B 
(RPS0BB, MGY628. Kindly provided by Sherif Abou Elela’s lab 
at Sherbrooke University) 
yJD1740 
Mat a ura3Δ0 lys2Δ0 leu2Δ0 his3Δ200 rps0b::RPS0A 
(RPS0AA, MGY629. Kindly provided by Sherif Abou Elela’s lab 
at Sherbrooke University) 
yJD1741 
Mat a ura3Δ0 lys2Δ0 leu2Δ0 his3Δ200 rps14a::RPS14B 
(RPS14BB, MGY630. Kindly provided by Sherif Abou Elela’s 
lab at Sherbrooke University) 
yJD1742 
Mat a ura3Δ0 lys2Δ0 leu2Δ0 his3Δ200 rps14b::RPS14A 
(RPS14AA, MGY631. Kindly provided by Sherif Abou Elela’s 
lab at Sherbrooke University) 
yJD1743 
Mat a ura3Δ0 lys2Δ0 leu2Δ0 his3Δ200 rps19a::RPS19B 
(RPS19BB, MGY632. Kindly provided by Sherif Abou Elela’s 
lab at Sherbrooke University) 
yJD1744 
Mat a ura3Δ0 lys2Δ0 leu2Δ0 his3Δ200 rps19b::RPS19A  
(RPS19AA, MGY633. Kindly provided by Sherif Abou Elela’s 







Appendix 2: Plasmids 
 
Table 6. Plasmids used in this study 
Plasmids Description Usage 
pJD375 pYDL-Readthrough Yeast DL assays 
pJD376 pYDL-LA Yeast DL assays 
pJD377 pYDL-Ty1/EST3 Yeast DL assays 
pJD431 pYDL-UAA Yeast DL assays 
pJD432 pYDL-UAG Yeast DL assays 








Yeast DL assays 
pJD1018 pYDL-EST2 Yeast DL assays 
pJD1039 pYDL-STN1 Yeast DL assays 
pJD1041 pYDL-EST1 Yeast DL assays 
pJD2257 pSGDmod-Readthrough 
DL assay – DBA 
LCLs 
pJD2337 pSGDmod-PEG10 
DL assay – DBA 
LCLs 
pJD2349 pSGDmod-OAZ1 
DL assay – DBA 
LCLs 
pJD2443 pSGDmod-UAA 
DL assay – DBA 
LCLs 
pJD2444 pSGDmod-UGA 
DL assay – DBA 
LCLs 
pJD2445 pSGDmod-UAG 
DL assay – DBA 
LCLs 
pJD1521 
pUG73 – Hegemann’s plasmid for 
yeast KO with LEU2 marker 
Yeast upf1 deletion 
pJD2044 pHDL-fullCMV-control 









pJD175f pHDL-SV40-control Cloning 
pJD1643 pHDL-SV40-UAA Cloning 
pJD2256 pSGDmod-HIV Cloning 





Appendix 3: Cell lines 
 
Table 7. Cell lines used in this study 
Cell line name Description 
Clinical 
phenotype 
NhnF Control LCL Healthy 
NhnM Control LCL Healthy 
F.T. Control LCL Healthy 
RPL9 c.-2+1 Chr4(GRCh37):g.39460510C>G DBA 




C109 Control fibroblast line Healthy 
9E0872 Control fibroblast line Healthy 
uS12 p.Arg67Lys uS12 R67K 
MacInnes 
Syndrome 
uS12 p.Phe120Ile uS12 F120I 
MacInnes 
Syndrome 
All cell lines were kindly provided by Dr. Alyson MacInnes, at European 








Appendix 4: Oligonucleotides 
 





DL_MCS seqng 147105020 CGTACGTGATGTTCACC 
yCBF5_seqng Fwd 128146839 
GGAGGATTTCGTTATTAAGCCTG
A 









DL_Pro2 150855015 CCACTGCGGACCAGTTATCATC 
Renilla_seq_f1 158697105 GTTTCCTCGTCATTGTTCTCG 
Renilla_seq_f2 158697106 GGTATGGGCAAATCAGGCAA 




Firefly_seq_f1 158697109 TCGCAGCCTACCGTAGT 
Firefly_seq_f2 158697110 CATTCTTCGCCAAAAGCACTCT 
Firefly_seq_f3 158697111 AACATCTTCGACGCGGG 
Firefly_seq_r1 158697112 GGCGTGAATGTAAGCGTG 
Firefly_seq_r2 158697113 GGTCCTCTGACACATAATTCGC 
Firefly_seq_r3 158697114 CATGCGAGAATCTGACGCAG 
Firefly_seq_r4 158697115 CACCTCGATATGTGCATCTGTA 
Renilla_seq_r1 158697116 GTACAACGTCAGGTTTACCACC 









pJD375_seq_f1 163946560 GGCGTTACCCAACTTAATCG 
pJD375_seq_f2 163946561 CGTTTACAATTTCCTGATGCGG 
pJD375_seq_f3 163946562 TCTGCCCATTCTGCTATTCTG 
pJD375_seq_f4 163946563 CAGACAAGCTGTGACCGT 
pJD375_seq_f5 163946564 TAGCAXGTGATGAAAAGGACCC 
pJD375_seq_f6 163946565 ATCATGTAACTCGCCTGGATCG 
pJD375_seq_f7 163946566 GCGTAATCTGCTGCTTGC 












pJD375_seq_r2 163946569 GTTGTCGTGGTCGTCATCAT 
pJD375_seq_r3 163946570 AATTGCGTTGCGCTCACTGC 
pJD375_seq_r4 163946571 GGATTAGCAGAGCGAGGTAT 
pJD375_seq_r5 163946572 GAAGTGGTCCTGCAACTTTATCC 
pJD375_seq_r6 163946573 GGCGACACGGAAATGTTGAA 
pJD375_seq_r7 163946574 GATACGAGGCGCGTGTAAGT 
pJD375_seq_r8 163946575 GTGTGCTTCATTGGATGTTCG 
pJD375_seq_r9 163946576 ATGCTAAGGTAGAGGGTG 
pJD375_seq_r10 163946577 CGTGGCGAGAAAGGAAGGGA 
SGDluc-F4 159513400 AAGATGTTCATCGAGTCCGACC 
SGDluc-R5 159513414 CGCTTCATAGCTTCTGCCAGC 
All oligonucleotides on this list were obtained from IDT. 


















Oligo B for KO yUPF1 133698646 
CGGTATCCCCTAAGTCAGAATCT
GGATGTAAAG 
Oligo C for KO yUPF1 133698647 
CGGCCAATGAACGCTCAATTTAA
CGTAGAATCTG 






Oligo B-M for KO 
yUPF1 (LEU2 marker) 
138576612 AGTTATCCTTGGATTTGG 
Oligo C-M for KO 
yUPF1 (LEU2 marker) 
138576613 ATCTCATGGATGATATCC 















































Table 11. Gene fragments used for cloning 
Gene Fragments Sequence 
Gene fragment for HIV -
1 PRF insertion into 


















Gene fragment for 
PEG10insertion into 






Gene fragment for OAZ1 
+1 PRF insertion into 








All gene fragments on this list were obtained from Genewiz. 
 




HAC1_fwd_splicing 189869741 GGAAACAGTCTACCCTTTGACAAT 
HAC1_rev_splicing 189869742 TCATGAAGTGATGAAGAAATCATTC 






Appendix 5: CBF5 RNA-Seq supplementary data 
 
An RNA-Seq experiment was carried out with isogenic WT and cbf5-
D95A yeast cells to 1) determine the effects of reduced pseudouridylation of 
yeast rRNA on gene expression, and 2) identify messages containing functional 
-1 PRF signals. RNA-Seq data analysis is described in chapter 3, and in more 
detail in Materials and Methods (chapter 2). Sets of differentially expressed 
genes and pathways are contained within this dissertation and in an online 
repository at https://github.com/cmsvieira/scerevisiae_cbf5. 
A small number of messages with predicted -1 PRF had low abundance 
in the cbf5-D95A cells. In an effort to rescue the abundance of -1 PRF-
containing messages, UPF1 (involved in NMD pathway) was deleted from the 
CBF5 and cbf5-D95A strains. The RNA-Seq experiment was then repeated 
with CBF5, cbf5-D95A, upf1Δ and cbf5-D95A upf1Δ. As before, data analysis 
is described in chapter 3, and in more detail in Materials and Methods (chapter 
2). 
The purpose of this appendix is to include supplementary data relating 
to the RNA-Seq experiments described in chapter 3. 
 
SRA accessions 
Sequencing data have been submitted to Genbank, with Bioproject 
accession number PRJNA475276, for project SRP150277. Biosample 





Table 13. Genbank accession numbers for RNA-Seq data 
Biosample accession Library ID Title 
SAMN09384240 HPGL0564 CBF5 UPF1.E1.1 
SAMN09384241 HPGL0565 CBF5 UPF1.E1.2 
SAMN09384242 HPGL0566 CBF5 UPF1.E1.3 
SAMN09384243 HPGL0567 CBF5 UPF1.E1.4 
SAMN09384244 HPGL0568 cbf5-D95A UPF1.E1.1 
SAMN09384245 HPGL0569 cbf5-D95A UPF1.E1.2 
SAMN09384246 HPGL0570 cbf5-D95A UPF1.E1.3 
SAMN09384247 HPGL0571 cbf5-D95A UPF1.E1.4 
SAMN09384248 HPGL0774 CBF5 UPF1.E2B1.1 
SAMN09384249 HPGL0775 cbf5-D95A UPF1.E2B1.1 
SAMN09384250 HPGL0776 CBF5 upf1delta.E2B1.1 
SAMN09384251 HPGL0777 cbf5-D95A upf1delta.E2B1.1 
SAMN09384252 HPGL0778 CBF5 UPF1.E2B1.2 
SAMN09384253 HPGL0779 cbf5-D95A UPF1.E2B1.2 
SAMN09384254 HPGL0780 CBF5 upf1delta.E2B1.2 
SAMN09384255 HPGL0781 cbf5-D95A upf1delta.E2B1.2 
SAMN09384256 HPGL0782 CBF5 UPF1.E2B2.1 
SAMN09384257 HPGL0783 cbf5-D95A UPF1.E2B2.1 
SAMN09384258 HPGL0784 CBF5 upf1delta.E2B2.1 
SAMN09384259 HPGL0785 cbf5-D95A upf1delta.E2B2.1 
SAMN09384260 HPGL0786 CBF5 UPF1.E2B2.2 
SAMN09384261 HPGL0787 cbf5-D95A UPF1.E2B2.2 
SAMN09384262 HPGL0788 CBF5 upf1delta.E2B2.2 







Figure 34. Library sizes for all samples in RNA-seq experiments 







Figure 35. Quality control metrics reveal no outliers in E1 
Hierarchical clustering analyses using (A) Pearson correlation and (B) 
Euclidean distances along with a (C) Principal Component Analyses of the log2, 











Figure 36. Screenshot from Integrated Genomics Viewer (IGV) displaying 
peculiar pattern of E2B1 in a region of chromosome XII 
Genes in this region of chromosome XII and sample IDs are labeled. Red 
arrows point at samples hpgl0774, hpgl0776, hpgl0778, and hpgl0780 (from 









Figure 37. Screenshot from Integrated Genomics Viewer (IGV) displaying 
peculiar pattern of E2B1 in a region of chromosome IX 
Genes in this region of chromosome IX and sample IDs are labeled. Red 
arrows point at samples hpgl0774, hpgl0776, hpgl0778, and hpgl0780 (from 
top to bottom arrow), part of batch E2B1. 
 
Gene Ontology (GO) Analyses 
A set of differentially expressed genes (fold-change ≥ 2, adjusted P 
value < 0.05) in each contrast was created, and gene ontology (GO) analyses 
were carried out. Each table below has up to top 10 biological processes (BP) 
and 10 molecular functions (MF) GO terms found in the analysis of each 
contrast. Tables 14 through 17 below are discussed within chapter 3. Complete 
results of the analyses can be found in Datasets 
E1E2_gprofiler_up_20180212.xlsx and E1E2_gprofiler_down_20180212.xlsx 


























Table 14. Top 20 gene ontology (GO) categories (biological processes, 
BP and metabolic functions, MF) enriched for upf1Δ vs. WT 











5.96E-08 57 350 
GO:0051321 
meiotic cell cycle 
(BP) 
7.34E-08 1751 308 
GO:0048646 
anatomical structure 
formation involved in 
morphogenesis (BP) 
3.54E-07 36 181 
GO:0030435 
sporulation resulting 
in formation of a 
cellular spore (BP) 





5.21E-07 54 355 










1.03E-06 33 170 
GO:1903046 
meiotic cell cycle 
process (BP) 













































metal ions, NAD or 
NADP as acceptor 
(MF) 














1.05E-03 10 34 
upf1Δ vs. WT, down-regulated 
GO:0003735 
structural constituent 
of ribosome (MF) 





















1.04E-14 168 776 




















































2.57E-04 21 55 










movement of ions, 
rotational 
mechanism (MF) 
2.45E-02 10 21 
GO:0008144 drug binding (MF) 4.85E-02 5 6 
Cutoff for DE genes: fold change ≥ 2, adjusted P value cutoff of <0.05, by 
DEseq2. Number of DE genes and total number of genes in each of the top 20 
GO terms are shown. 
 
Table 15. Top 20 GO categories (BP and MF) enriched for cbf5-D95A 
upf1Δ vs. cbf5-D95A 






cbf5-D95A upf1Δ vs. cbf5-D95A, up-regulated 
GO:0051321 
meiotic cell cycle 
(BP) 





4.14E-09 63 355 
GO:1903046 
meiotic cell cycle 
process (BP) 
1.22E-07 50 267 



























7.04E-06 20 68 
GO:0048646 
anatomical structure 
formation involved in 
morphogenesis (BP) 




2.46E-05 82 436 
GO:0030435 
sporulation resulting 
in formation of a 
cellular spore (BP) 






4.03E-05 40 170 















metal ions, NAD or 
NADP as acceptor 
(MF) 































cbf5-D95A upf1Δ vs. cbf5-D95A, down-regulated 
GO:0003735 
structural constituent 
of ribosome (MF) 




























7.20E-10 171 776 
















3.28E-08 22 36 














2.19E-04 12 35 
GO:0016684 
oxidoreductase 
activity, acting on 
peroxide as acceptor 
(MF) 






















3.82E-04 14 28 
Cutoff for DE genes: fold change ≥ 2, adjusted P value cutoff of <0.05, by 
DEseq2. Number of DE genes and total number of genes in each of the top 20 
GO terms are shown. 
 
Table 16. Top 20 GO categories (BP and MF) enriched for cbf5-D95A 
upf1Δ vs. upf1Δ 


































































9.30E-05 9 32 
GO:0031505 
fungal-type cell wall 
organization (BP) 





2.85E-04 9 36 
GO:0016614 
oxidoreductase 
activity, acting on 
CH-OH group of 
donors (MF) 






2.93E-03 17 170 
GO:0016616 
oxidoreductase 
activity, acting on 
the CH-OH group of 
donors, NAD or 
NADP as acceptor 
(MF) 


























2.03E-02 3 4 
cbf5-D95A upf1Δ vs. upf1Δ, down-regulated 
GO:0007049 cell cycle (BP) 6.59E-11 39 783 
GO:0022402 
cell cycle process 
(BP) 
5.01E-10 34 627 
GO:0000278 
mitotic cell cycle 
(BP) 












mitotic cell cycle 
process (BP) 









1.70E-04 33 1288 




3.83E-04 17 299 
GO:0044770 
cell cycle phase 
transition (BP) 
2.08E-03 11 170 
GO:0044772 
mitotic cell cycle 
phase transition 
(BP) 
2.08E-03 11 170 
GO:0005200 
structural constituent 
of cytoskeleton (MF) 





2.03E-02 3 5 
Cutoff for DE genes: fold change ≥ 2, adjusted P value cutoff of <0.05, by 
DEseq2. Number of DE genes and total number of genes in each of the top 20 
GO terms are shown.  
 
Table 17. Top 20 GO categories (BP and MF) enriched for cbf5-D95A 
upf1Δ vs. WT 










7.75E-15 117 462 








1.94E-09 10 11 
GO:0031505 
fungal-type cell wall 
organization (BP) 
2.04E-09 53 204 
GO:1901678 
iron coordination 
entity transport (BP) 
















8.79E-09 59 250 
GO:0071555 
cell wall organization 
(BP) 
8.79E-09 59 250 
GO:0071852 
fungal-type cell wall 
organization or 
biogenesis (BP) 

















































































































9.25E-13 204 845 
GO:0003735 
structural constituent 
of ribosome (MF) 




2.33E-51 188 396 

































factor binding (MF) 





1.38E-02 3 7 
GO:0019843 rRNA binding (MF) 2.92E-02 41 145 
Cutoff for DE genes: fold change ≥ 2, adjusted P value cutoff of <0.05, by 
DEseq2. Number of DE genes and total number of genes in each of the top 20 
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